Defining the risk of SARS-CoV-2 variants on immune protection
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute o...
Saved in:
| Published in | Nature (London) Vol. 605; no. 7911; pp. 640 - 652 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
Nature Publishing Group UK
26.05.2022
Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures.
The SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme provides a real-time risk assessment of SARS-CoV-2 variants with the potential to affect transmission, virulence and resistance to infection- and vaccine-induced immunity. |
|---|---|
| AbstractList | The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures. The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variantsjeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment ofViral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component ofthe US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures. The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures. The SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme provides a real-time risk assessment of SARS-CoV-2 variants with the potential to affect transmission, virulence and resistance to infection- and vaccine-induced immunity. The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced following infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) program. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants potentially impacting transmission, virulence, and resistance to convalescent and vaccine-induced immunity. The SAVE program serves as a critical data-generating component of the United States Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines, and therapeutics and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity, and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models, and pivotal findings facilitated by this collaborative approach and identify future challenges. This program serves as a template for the response against rapidly evolving pandemic pathogens by monitoring viral evolution in the human population to identify variants that could erode the effectiveness of countermeasures. The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures.The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversity, the National Institute of Allergy and Infectious Diseases within the National Institutes of Health established the SARS-CoV-2 Assessment of Viral Evolution (SAVE) programme. This effort was designed to provide a real-time risk assessment of SARS-CoV-2 variants that could potentially affect the transmission, virulence, and resistance to infection- and vaccine-induced immunity. The SAVE programme is a critical data-generating component of the US Government SARS-CoV-2 Interagency Group to assess implications of SARS-CoV-2 variants on diagnostics, vaccines and therapeutics, and for communicating public health risk. Here we describe the coordinated approach used to identify and curate data about emerging variants, their impact on immunity and effects on vaccine protection using animal models. We report the development of reagents, methodologies, models and notable findings facilitated by this collaborative approach and identify future challenges. This programme is a template for the response to rapidly evolving pathogens with pandemic potential by monitoring viral evolution in the human population to identify variants that could reduce the effectiveness of countermeasures. |
| Author | Douek, Daniel C. García-Sastre, Adolfo Krammer, Florian Sedova, Mayya Ferrari, Guido Trifkovic, Sanja Rockx, Barry Shabman, Reed S. VanBlargan, Laura A. Fouchier, Ron A. M. Franks, John Menachery, Vineet D. Buchser, William J. Rothlauf, Paul W. Shi, Pei-Yong Koopmans, Marion P. G. Yoon, Hyejin McDermott, Adrian B. Wang, Maple Koren, Eilay Bloom, Jesse D. O’Dell, Sijy Niewiadomska, Anna M. Gonzalez-Reiche, Ana Silvia Godzik, Adam Bratt, Debbie L. Di, Han Amara, Rama R. Rolland, Morgane McElrath, Margaret J. Logue, James P. Haagmans, Bart L. Ho, David D. Schotsaert, Michael Fabrizio, Thomas P. Florence, William C. Post, Diane J. Dearlove, Bethany L. Shen, Xiaoying Nair, Manoj S. Fischer, Will M. Jeevan, Trushar Munt, Jenny E. Schultz-Cherry, Stacey Wallace, Zachary S. Ellebedy, Ali Gordon, Aubree Holbrook, Michael R. van Bakel, Harm Simon, Viviana Sullivan, Nancy J. Wentworth, David E. Davis-Gardner, Meredith E. Huang, Yaoxing Drosten, Christian Barouch, Dan H. Perlman, Stanley Bonenfant, Gaston Weiss, Carol D. LeGresley, Eric B. Wilks, Samuel H. |
| AuthorAffiliation | 8 University of California Riverside School of Medicine, Riverside, CA, USA 56 Departments of Medicine, Washington University School of Medicine, St. Louis, MO, USA 31 The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA 32 Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA 43 The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev, Beer Sheva, Israel 3 Systems Genomics Section, Laboratory of Parasitic Diseases, Rockville, MD, USA 21 National Institute for Biotechnology in the Negev, Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, Be’er-Sheva, Israel 45 Fred Hutchinson Cancer Research Center, Seattle, WA, USA 9 Ragon Institute of MGH, MIT, and Harvard, Boston, MA, USA 17 Washington University in St. Louis, St. Louis, MO, USA 23 US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine |
| AuthorAffiliation_xml | – name: 37 National Institute of Allergy and Infectious Diseases Integrated Research Facility, Frederick, MD, USA – name: 18 Vaccine Research Center, Rockville, MD, USA – name: 49 Department of Informatics, J. Craig Venter Institute, La Jolla, CA, USA – name: 59 Department of Computer Science and Engineering, University of California, San Diego, CA, USA – name: 19 CAMRIS, Contractor for NIAID, Bethesda, MD, USA – name: 6 Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, USA – name: 29 Department Viroscience, Erasmus MC, Rotterdam, The Netherlands – name: 10 Department of Microbiology and Immunology, Emory Vaccine Center, Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA, USA – name: 58 Department of Informatics, J. Craig Venter Institute, La Jolla, CA, USA – name: 21 National Institute for Biotechnology in the Negev, Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, Be’er-Sheva, Israel – name: 45 Fred Hutchinson Cancer Research Center, Seattle, WA, USA – name: 52 Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA – name: 3 Systems Genomics Section, Laboratory of Parasitic Diseases, Rockville, MD, USA – name: 31 The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA – name: 55 Data Science and Learning Division, Argonne National Laboratory, Argonne, IL, USA, Sinai, New York, NY, USA – name: 22 Center for Childhood Infections and Vaccines of Children’s Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA – name: 28 Department of Surgery, Duke University Medical Center, Durham, NC, USA – name: 50 Dept. of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA – name: 40 Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, Japan – name: 46 Department of Microbiology and Immunology, Institute for Human Infection and Immunity, World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, TX, USA – name: 36 Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA – name: 14 Fred Hutch Cancer Center, Howard Hughes Medical Institute, Seattle, WA, USA – name: 44 Broad Institute of MIT and Harvard, Boston, MA, USA – name: 20 High Throughput Screening Center, Washington University School of Medicine, St. Louis, St. Louis, MO, USA – name: 62 Departments of Medicine, Molecular Microbiology, Pathology & Immunology, The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA – name: 41 Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN, USA – name: 61 Department of Microbiology, Immunology and Genetics Faculty of Health Sciences Ben-Gurion University of the Negev, Beer Sheva, Israel – name: 8 University of California Riverside School of Medicine, Riverside, CA, USA – name: 11 Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA – name: 4 Center for Pathogen Research, The Department of Microbiology and Immunology, The University of Maryland School of Medicine, Baltimore, MD, USA – name: 38 University of Cambridge, Center for Pathogen Evolution, Department of Zoology, UK – name: 32 Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA – name: 54 University of Chicago Consortium for Advanced Science and Engineering, University of Chicago, Chicago, IL, USA – name: 56 Departments of Medicine, Washington University School of Medicine, St. Louis, MO, USA – name: 1 National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA – name: 35 Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI, USA – name: 53 Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX, USA – name: 23 US Military HIV Research Program; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; Walter Reed Army Institute of Research, USA – name: 47 Duke University Medical Center, Durham, NC, USA – name: 33 Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA – name: 34 Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA – name: 15 Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA – name: 42 Los Alamos National Laboratory, New Mexico Consortium, Los Alamos, NM, USA – name: 16 CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention, Atlanta, GA, USA – name: 12 Department of Microbiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA – name: 2 Division of Microbiology and Infectious Diseases, Rockville, MD, USA – name: 25 Institute of Virology, Charité – Universitätsmedizin and German Center for Infection Research (DZIF), Associated Partner Site, Berlin, Germany – name: 51 Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, USA – name: 48 Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USA – name: 39 Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan – name: 27 St. Jude Children’s Research Hospital, Memphis, TN, USA – name: 13 Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA – name: 5 Department of Microbiology, Icahn School of Medicine at Mount Sinai, USA – name: 60 US Food and Drug Administration, Center for Biologics Evaluation and Research, USA – name: 9 Ragon Institute of MGH, MIT, and Harvard, Boston, MA, USA – name: 24 Microbiology Department, New York University Grossman School of Medicine, New York, NY, USA – name: 43 The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev, Beer Sheva, Israel – name: 30 Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA – name: 26 Department of Pathology and Immunology Washington University School of Medicine, St. Louis, MO, USA – name: 57 Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN, USA – name: 17 Washington University in St. Louis, St. Louis, MO, USA – name: 7 Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA |
| Author_xml | – sequence: 2 givenname: Elodie orcidid: 0000-0002-1515-725X surname: Ghedin fullname: Ghedin, Elodie organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Systems Genomics Section, Laboratory of Parasitic Diseases, National Institutes of Health – sequence: 4 givenname: Florian orcidid: 0000-0003-4121-776X surname: Krammer fullname: Krammer, Florian email: florian.krammer@mssm.edu organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai – sequence: 5 givenname: Alba orcidid: 0000-0002-2209-5966 surname: Grifoni fullname: Grifoni, Alba organization: Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology – sequence: 7 givenname: Galit orcidid: 0000-0002-7680-9215 surname: Alter fullname: Alter, Galit organization: Ragon Institute of MGH, MIT, and Harvard – sequence: 9 givenname: Ralph S. orcidid: 0000-0001-6827-8701 surname: Baric fullname: Baric, Ralph S. organization: Department of Epidemiology, University of North Carolina at Chapel Hill, Department of Microbiology, University of North Carolina at Chapel Hill – sequence: 10 givenname: Dan H. orcidid: 0000-0001-5127-4659 surname: Barouch fullname: Barouch, Dan H. organization: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center – sequence: 12 givenname: Louis-Marie orcidid: 0000-0002-5648-3190 surname: Bloyet fullname: Bloyet, Louis-Marie organization: Department of Molecular Microbiology, Washington University School of Medicine – sequence: 13 givenname: Gaston surname: Bonenfant fullname: Bonenfant, Gaston organization: CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention – sequence: 14 givenname: Adrianus C. M. orcidid: 0000-0002-4700-8224 surname: Boon fullname: Boon, Adrianus C. M. organization: Department of Medicine, Washington University in St Louis – sequence: 15 givenname: Eli A. surname: Boritz fullname: Boritz, Eli A. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 16 givenname: Debbie L. orcidid: 0000-0002-5822-5558 surname: Bratt fullname: Bratt, Debbie L. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institutes of Health, CAMRIS, Contractor for NIAID – sequence: 17 givenname: Traci L. surname: Bricker fullname: Bricker, Traci L. organization: Department of Medicine, Washington University in St Louis – sequence: 18 givenname: Liliana surname: Brown fullname: Brown, Liliana organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institutes of Health – sequence: 19 givenname: William J. orcidid: 0000-0002-6675-6359 surname: Buchser fullname: Buchser, William J. organization: High Throughput Screening Center, Washington University School of Medicine – sequence: 20 givenname: Juan Manuel surname: Carreño fullname: Carreño, Juan Manuel organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai – sequence: 22 givenname: Tamarand L. surname: Darling fullname: Darling, Tamarand L. organization: Department of Medicine, Washington University in St Louis – sequence: 25 givenname: Han surname: Di fullname: Di, Han organization: CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention – sequence: 26 givenname: Meike surname: Dittmann fullname: Dittmann, Meike organization: Microbiology Department, New York University Grossman School of Medicine – sequence: 27 givenname: Nicole A. surname: Doria-Rose fullname: Doria-Rose, Nicole A. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 28 givenname: Daniel C. surname: Douek fullname: Douek, Daniel C. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 29 givenname: Christian orcidid: 0000-0001-7923-0519 surname: Drosten fullname: Drosten, Christian organization: Institute of Virology, Charité–Universitätsmedizin and German Center for Infection Research (DZIF) – sequence: 30 givenname: Venkata-Viswanadh orcidid: 0000-0001-9321-7839 surname: Edara fullname: Edara, Venkata-Viswanadh organization: Center for Childhood Infections and Vaccines of Children’s Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine – sequence: 31 givenname: Ali orcidid: 0000-0002-6129-2532 surname: Ellebedy fullname: Ellebedy, Ali organization: Department of Pathology and Immunology, Washington University School of Medicine – sequence: 32 givenname: Thomas P. orcidid: 0000-0002-8960-0728 surname: Fabrizio fullname: Fabrizio, Thomas P. organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 33 givenname: Guido surname: Ferrari fullname: Ferrari, Guido organization: Department of Surgery, Duke University Medical Center – sequence: 34 givenname: Will M. surname: Fischer fullname: Fischer, Will M. organization: Los Alamos National Laboratory, New Mexico Consortium – sequence: 35 givenname: William C. surname: Florence fullname: Florence, William C. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institutes of Health – sequence: 37 givenname: John surname: Franks fullname: Franks, John organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 38 givenname: Adolfo orcidid: 0000-0002-6551-1827 surname: García-Sastre fullname: García-Sastre, Adolfo organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai – sequence: 39 givenname: Adam orcidid: 0000-0002-2425-852X surname: Godzik fullname: Godzik, Adam organization: University of California Riverside School of Medicine – sequence: 40 givenname: Ana Silvia orcidid: 0000-0003-3583-4497 surname: Gonzalez-Reiche fullname: Gonzalez-Reiche, Ana Silvia organization: Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai – sequence: 41 givenname: Aubree orcidid: 0000-0002-9352-7877 surname: Gordon fullname: Gordon, Aubree organization: Department of Epidemiology, University of Michigan – sequence: 42 givenname: Bart L. orcidid: 0000-0001-6221-2015 surname: Haagmans fullname: Haagmans, Bart L. organization: Department Viroscience, Erasmus MC – sequence: 43 givenname: Peter J. surname: Halfmann fullname: Halfmann, Peter J. organization: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin – sequence: 45 givenname: Michael R. orcidid: 0000-0002-0824-2667 surname: Holbrook fullname: Holbrook, Michael R. organization: National Institute of Allergy and Infectious Diseases Integrated Research Facility – sequence: 47 givenname: Sarah L. orcidid: 0000-0002-6969-1167 surname: James fullname: James, Sarah L. organization: Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 48 givenname: Lukasz surname: Jaroszewski fullname: Jaroszewski, Lukasz organization: University of California Riverside School of Medicine – sequence: 50 givenname: Robert M. orcidid: 0000-0002-1976-7688 surname: Johnson fullname: Johnson, Robert M. organization: Center for Pathogen Research, Department of Microbiology and Immunology, The University of Maryland School of Medicine – sequence: 51 givenname: Terry C. orcidid: 0000-0003-1120-9531 surname: Jones fullname: Jones, Terry C. organization: Institute of Virology, Charité–Universitätsmedizin and German Center for Infection Research (DZIF), Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 53 givenname: Yoshihiro orcidid: 0000-0001-5061-8296 surname: Kawaoka fullname: Kawaoka, Yoshihiro organization: Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin, Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Disease Control and Prevention Center, National Center for Global Health and Medicine Hospital – sequence: 54 givenname: Lisa orcidid: 0000-0001-6300-0452 surname: Kercher fullname: Kercher, Lisa organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 55 givenname: Marion P. G. orcidid: 0000-0002-5204-2312 surname: Koopmans fullname: Koopmans, Marion P. G. organization: Department Viroscience, Erasmus MC – sequence: 56 givenname: Bette orcidid: 0000-0002-2026-5757 surname: Korber fullname: Korber, Bette organization: Los Alamos National Laboratory, New Mexico Consortium – sequence: 57 givenname: Eilay surname: Koren fullname: Koren, Eilay organization: National Institute for Biotechnology in the Negev, Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev – sequence: 59 givenname: Eric B. orcidid: 0000-0002-5286-5693 surname: LeGresley fullname: LeGresley, Eric B. organization: Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 62 givenname: Zhuoming orcidid: 0000-0001-8198-0976 surname: Liu fullname: Liu, Zhuoming organization: Department of Molecular Microbiology, Washington University School of Medicine – sequence: 63 givenname: Brandi surname: Livingston fullname: Livingston, Brandi organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 64 givenname: James P. orcidid: 0000-0002-7410-9741 surname: Logue fullname: Logue, James P. organization: Center for Pathogen Research, Department of Microbiology and Immunology, The University of Maryland School of Medicine – sequence: 65 givenname: Yang orcidid: 0000-0003-3277-8792 surname: Luo fullname: Luo, Yang organization: Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons – sequence: 66 givenname: Adrian B. orcidid: 0000-0003-0616-9117 surname: McDermott fullname: McDermott, Adrian B. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 67 givenname: Margaret J. surname: McElrath fullname: McElrath, Margaret J. organization: Fred Hutchinson Cancer Research Center – sequence: 69 givenname: Vineet D. orcidid: 0000-0001-8803-7606 surname: Menachery fullname: Menachery, Vineet D. organization: Department of Microbiology and Immunology, Institute for Human Infection and Immunity, World Reference Center for Emerging Viruses and Arboviruses, University of Texas Medical Branch – sequence: 71 givenname: Barbara surname: Mühlemann fullname: Mühlemann, Barbara organization: Institute of Virology, Charité–Universitätsmedizin and German Center for Infection Research (DZIF), Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 73 givenname: Jenny E. surname: Munt fullname: Munt, Jenny E. organization: Department of Epidemiology, University of North Carolina at Chapel Hill – sequence: 74 givenname: Manoj S. orcidid: 0000-0002-5994-3957 surname: Nair fullname: Nair, Manoj S. organization: Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons – sequence: 75 givenname: Antonia orcidid: 0000-0001-8034-2382 surname: Netzl fullname: Netzl, Antonia organization: Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 77 givenname: Sijy surname: O’Dell fullname: O’Dell, Sijy organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 78 givenname: Andrew orcidid: 0000-0003-3248-1761 surname: Pekosz fullname: Pekosz, Andrew organization: Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health – sequence: 79 givenname: Stanley orcidid: 0000-0003-4213-2354 surname: Perlman fullname: Perlman, Stanley organization: Department of Microbiology and Immunology, University of Iowa – sequence: 80 givenname: Marjorie C. surname: Pontelli fullname: Pontelli, Marjorie C. organization: Department of Molecular Microbiology, Washington University School of Medicine – sequence: 83 givenname: Paul W. orcidid: 0000-0002-0941-4467 surname: Rothlauf fullname: Rothlauf, Paul W. organization: Department of Molecular Microbiology, Washington University School of Medicine – sequence: 84 givenname: Sinai surname: Sacharen fullname: Sacharen, Sinai organization: National Institute for Biotechnology in the Negev, Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, The Shraga Segal Department of Microbiology and Immunology, Ben-Gurion University of the Negev – sequence: 85 givenname: Richard H. orcidid: 0000-0003-1355-892X surname: Scheuermann fullname: Scheuermann, Richard H. organization: Department of Informatics, J. Craig Venter Institute – sequence: 86 givenname: Stephen D. surname: Schmidt fullname: Schmidt, Stephen D. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 87 givenname: Michael orcidid: 0000-0003-3156-3132 surname: Schotsaert fullname: Schotsaert, Michael organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai – sequence: 88 givenname: Stacey orcidid: 0000-0002-2021-727X surname: Schultz-Cherry fullname: Schultz-Cherry, Stacey organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 89 givenname: Robert A. orcidid: 0000-0003-3133-0849 surname: Seder fullname: Seder, Robert A. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Vaccine Research Center – sequence: 90 givenname: Mayya surname: Sedova fullname: Sedova, Mayya organization: University of California Riverside School of Medicine – sequence: 92 givenname: Reed S. orcidid: 0000-0003-3272-3484 surname: Shabman fullname: Shabman, Reed S. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institutes of Health – sequence: 93 givenname: Xiaoying surname: Shen fullname: Shen, Xiaoying organization: Department of Surgery, Duke University Medical Center – sequence: 94 givenname: Pei-Yong orcidid: 0000-0001-5553-1616 surname: Shi fullname: Shi, Pei-Yong organization: Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch – sequence: 95 givenname: Maulik surname: Shukla fullname: Shukla, Maulik organization: University of Chicago Consortium for Advanced Science and Engineering, University of Chicago, Data Science and Learning Division, Argonne National Laboratory – sequence: 96 givenname: Viviana orcidid: 0000-0002-6416-5096 surname: Simon fullname: Simon, Viviana organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai – sequence: 97 givenname: Spencer surname: Stumpf fullname: Stumpf, Spencer organization: Department of Molecular Microbiology, Washington University School of Medicine – sequence: 99 givenname: Larissa B. orcidid: 0000-0002-9380-6569 surname: Thackray fullname: Thackray, Larissa B. organization: Department of Medicine, Washington University in St Louis – sequence: 100 givenname: James surname: Theiler fullname: Theiler, James organization: Los Alamos National Laboratory, New Mexico Consortium – sequence: 101 givenname: Paul G. orcidid: 0000-0001-7955-0256 surname: Thomas fullname: Thomas, Paul G. organization: Department of Immunology, St Jude Children’s Research Hospital – sequence: 102 givenname: Sanja orcidid: 0000-0002-0710-9514 surname: Trifkovic fullname: Trifkovic, Sanja organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 104 givenname: Samuel A. surname: Turner fullname: Turner, Samuel A. organization: Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 105 givenname: Maria A. surname: Vakaki fullname: Vakaki, Maria A. organization: High Throughput Screening Center, Washington University School of Medicine – sequence: 106 givenname: Harm orcidid: 0000-0002-1376-6916 surname: van Bakel fullname: van Bakel, Harm organization: Department of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai – sequence: 107 givenname: Laura A. orcidid: 0000-0002-8922-8946 surname: VanBlargan fullname: VanBlargan, Laura A. organization: Department of Medicine, Washington University in St Louis – sequence: 108 givenname: Leah R. orcidid: 0000-0001-9262-1813 surname: Vincent fullname: Vincent, Leah R. organization: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Division of Microbiology and Infectious Diseases, National Institutes of Health – sequence: 109 givenname: Zachary S. orcidid: 0000-0003-0237-501X surname: Wallace fullname: Wallace, Zachary S. organization: Department of Informatics, J. Craig Venter Institute, Department of Computer Science and Engineering, University of California – sequence: 110 givenname: Li surname: Wang fullname: Wang, Li organization: CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention – sequence: 111 givenname: Maple surname: Wang fullname: Wang, Maple organization: Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons – sequence: 112 givenname: Pengfei orcidid: 0000-0003-2454-7652 surname: Wang fullname: Wang, Pengfei organization: Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons – sequence: 113 givenname: Wei surname: Wang fullname: Wang, Wei organization: Center for Biologics Evaluation and Research, US Food and Drug Administration – sequence: 115 givenname: Richard J. orcidid: 0000-0002-4397-7132 surname: Webby fullname: Webby, Richard J. organization: Department of Infectious Diseases, St Jude Children’s Research Hospital – sequence: 117 givenname: David E. orcidid: 0000-0002-5190-980X surname: Wentworth fullname: Wentworth, David E. organization: CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention – sequence: 119 givenname: Sean P. J. orcidid: 0000-0003-1564-8590 surname: Whelan fullname: Whelan, Sean P. J. organization: Department of Molecular Microbiology, Washington University School of Medicine – sequence: 120 givenname: Bradley M. orcidid: 0000-0001-6652-0701 surname: Whitener fullname: Whitener, Bradley M. organization: Department of Medicine, Washington University in St Louis – sequence: 121 givenname: Samuel H. surname: Wilks fullname: Wilks, Samuel H. organization: Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 122 givenname: Xuping orcidid: 0000-0003-0918-016X surname: Xie fullname: Xie, Xuping organization: Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch – sequence: 123 givenname: Baoling surname: Ying fullname: Ying, Baoling organization: Department of Medicine, Washington University in St Louis – sequence: 125 givenname: Bin surname: Zhou fullname: Zhou, Bin organization: CDC COVID-19 Emergency Response, Centers for Disease Control and Prevention – sequence: 126 givenname: Tomer orcidid: 0000-0002-0561-1578 surname: Hertz fullname: Hertz, Tomer email: thertz@bgu.ac.il organization: Department of Microbiology, Immunology and Genetics Faculty of Health Sciences Ben-Gurion University of the Negev – sequence: 127 givenname: Derek J. orcidid: 0000-0002-2393-1890 surname: Smith fullname: Smith, Derek J. email: djs200@cam.ac.uk organization: Center for Pathogen Evolution, Department of Zoology, University of Cambridge – sequence: 128 givenname: Michael S. orcidid: 0000-0002-8791-3165 surname: Diamond fullname: Diamond, Michael S. email: mdiamond@wustl.edu organization: Department of Medicine, Washington University in St Louis, Department of Pathology & Immunology, Washington University School of Medicine, Department of Molecular Microbiology, Washington University School of Medicine, The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine – sequence: 130 givenname: Mehul S. orcidid: 0000-0002-2686-8380 surname: Suthar fullname: Suthar, Mehul S. email: mehul.s.suthar@emory.edu organization: Center for Childhood Infections and Vaccines of Children’s Healthcare of Atlanta, Department of Pediatrics, Emory Vaccine Center, Emory University School of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35361968$$D View this record in MEDLINE/PubMed https://hal.science/hal-04794622$$DView record in HAL |
| BookMark | eNp9kUtv1DAUhS1URKeFP8ACRWIDC8P1M_YCpNHwKNJISBTYWm7izLgk9tRORuLf4yEtj1l0Zdn-zrmPc4ZOQgwOoacEXhFg6nXmRCiJgVIMXGrA4gFaEF5LzKWqT9ACgCoMislTdJbzNQAIUvNH6JQJJomWaoHevHOdDz5sqnHrquTzjyp21eXyyyVexe-YVnubvA1jrmKo_DBMwVW7FEfXjD6Gx-hhZ_vsntye5-jbh_dfVxd4_fnjp9VyjRsBasSU866lrdatEA1pWkYdQCsFbyiUq6gbkFYTaWsFLRMaaq1Ie6WAaWlVa9k5ejv77qarwbWNC2OyvdklP9j000Trzf8_wW_NJu6NZlwwyorBy9lgeyS7WK7N4Q14rbmkdE8K--K2WIo3k8ujGXxuXN_b4OKUDZVc1pQLyQv6_Ai9jlMKZRWFqkGqMp8s1LN_u_9T_y6FAqgZaFLMObnONH60hwWXYXxvCJhD4GYO3JTAze_AjShSeiS9c79XxGZRLnDYuPS37XtUvwAUxbo2 |
| CitedBy_id | crossref_primary_10_3390_genes15030361 crossref_primary_10_1002_advs_202405058 crossref_primary_10_1016_j_vaccine_2023_01_075 crossref_primary_10_3389_fmed_2022_934169 crossref_primary_10_1186_s12985_022_01940_w crossref_primary_10_3389_fnins_2023_1119943 crossref_primary_10_31829_2641_7456_ahs2022_6_1__010 crossref_primary_10_3390_jcm12010335 crossref_primary_10_1002_mco2_223 crossref_primary_10_3389_fpubh_2023_1146059 crossref_primary_10_1016_j_vaccine_2023_07_008 crossref_primary_10_1371_journal_ppat_1010970 crossref_primary_10_1016_j_ebiom_2023_104606 crossref_primary_10_3390_vaccines11111644 crossref_primary_10_1093_lifemeta_load019 crossref_primary_10_1038_s41467_022_31929_6 crossref_primary_10_1038_s41467_023_40033_2 crossref_primary_10_1016_j_celrep_2024_115140 crossref_primary_10_1038_s41420_022_01080_8 crossref_primary_10_1186_s12967_024_04852_1 crossref_primary_10_1016_j_ebiom_2023_104683 crossref_primary_10_1128_spectrum_01154_22 crossref_primary_10_1016_S0140_6736_22_02634_4 crossref_primary_10_3389_fitd_2022_988665 crossref_primary_10_1038_s41467_024_45690_5 crossref_primary_10_1093_ve_veac110 crossref_primary_10_1038_s41467_023_38867_x crossref_primary_10_3724_abbs_2024039 crossref_primary_10_3390_biology14010067 crossref_primary_10_1371_journal_pcbi_1012215 crossref_primary_10_3389_fimmu_2023_1324084 crossref_primary_10_3389_fpubh_2022_1010336 crossref_primary_10_1016_j_antiviral_2024_105970 crossref_primary_10_1186_s40001_022_00913_7 crossref_primary_10_1126_scitranslmed_adl1722 crossref_primary_10_1371_journal_ppat_1011805 crossref_primary_10_1016_j_ebiom_2023_104586 crossref_primary_10_1002_mco2_150 crossref_primary_10_3390_v14092032 crossref_primary_10_1128_jmbe_00100_24 crossref_primary_10_1038_s41598_024_76163_w crossref_primary_10_1080_21645515_2023_2275445 crossref_primary_10_1002_jmv_29189 crossref_primary_10_1016_j_heliyon_2024_e33229 crossref_primary_10_1016_j_cell_2023_02_001 crossref_primary_10_1038_s41541_023_00654_6 crossref_primary_10_1016_j_focus_2024_100186 crossref_primary_10_1128_spectrum_01099_23 crossref_primary_10_3390_genes14030681 crossref_primary_10_1038_s43856_023_00302_z crossref_primary_10_1016_j_chroma_2025_465685 crossref_primary_10_1016_j_immuni_2024_01_017 crossref_primary_10_1038_s41573_023_00672_y crossref_primary_10_3389_fimmu_2022_1011185 crossref_primary_10_1016_j_isci_2023_106230 crossref_primary_10_1038_s41541_023_00692_0 crossref_primary_10_3389_fimmu_2024_1383612 crossref_primary_10_3390_v15081630 crossref_primary_10_3390_vaccines11040713 crossref_primary_10_1021_acsnano_4c04212 crossref_primary_10_1038_s41392_023_01669_0 crossref_primary_10_1093_infdis_jiae215 crossref_primary_10_1016_j_xops_2023_100390 crossref_primary_10_1016_j_xcrm_2022_100849 crossref_primary_10_1038_s41467_024_46296_7 crossref_primary_10_1136_bmj_2022_072529 crossref_primary_10_1136_bmjph_2023_000833 crossref_primary_10_3389_fimmu_2023_1269916 crossref_primary_10_1093_immadv_ltad005 crossref_primary_10_1007_s00281_023_00996_2 crossref_primary_10_1128_mbio_02223_22 crossref_primary_10_1038_s41467_023_40185_1 crossref_primary_10_1107_S2059798324000329 crossref_primary_10_1016_j_gastha_2023_07_017 crossref_primary_10_1093_ve_vead055 crossref_primary_10_1038_s41392_023_01420_9 crossref_primary_10_1016_j_it_2023_03_002 crossref_primary_10_3724_abbs_2022147 crossref_primary_10_1128_mbio_01373_23 crossref_primary_10_1038_s41541_024_00888_y crossref_primary_10_1002_jmv_28831 crossref_primary_10_1038_s41590_024_01743_x crossref_primary_10_3390_life13020304 crossref_primary_10_1002_slct_202302906 crossref_primary_10_1021_acsnano_4c13146 crossref_primary_10_23736_S0393_0564_24_00013_0 crossref_primary_10_1128_msphere_00179_22 crossref_primary_10_1038_s41467_024_45193_3 crossref_primary_10_3389_fimmu_2022_946318 crossref_primary_10_1128_aac_01201_22 crossref_primary_10_1016_j_chom_2023_11_010 crossref_primary_10_1371_journal_pone_0312686 crossref_primary_10_1186_s12936_022_04199_2 crossref_primary_10_1128_jvi_00610_23 crossref_primary_10_3389_fbrio_2023_1258159 crossref_primary_10_1016_j_crimmu_2022_08_005 crossref_primary_10_1038_s41596_024_01022_x crossref_primary_10_3390_vaccines10091502 crossref_primary_10_1038_s43586_023_00236_9 crossref_primary_10_3390_diagnostics13071280 crossref_primary_10_3389_fbinf_2022_1020189 crossref_primary_10_1002_jmv_29268 crossref_primary_10_1001_jamanetworkopen_2024_19258 crossref_primary_10_1021_acsinfecdis_3c00203 crossref_primary_10_1128_spectrum_03406_23 crossref_primary_10_1089_vim_2023_0041 crossref_primary_10_3389_fbinf_2022_876380 crossref_primary_10_1016_j_celrep_2022_111968 crossref_primary_10_1186_s12967_023_03996_w crossref_primary_10_1038_s41589_023_01529_6 crossref_primary_10_1172_jci_insight_166602 |
| Cites_doi | 10.1126/sciimmunol.abh3634 10.1038/s41591-021-01488-2 10.1084/jem.20201993 10.1038/s41586-020-2943-z 10.1016/j.chom.2022.01.006 10.1002/cpmc.100 10.1126/science.abf4063 10.1126/scitranslmed.abh0755 10.1128/JVI.03030-12 10.1128/JVI.02012-06 10.1038/s41586-022-04399-5 10.1038/s41586-021-04388-0 10.1016/j.xcrm.2021.100290 10.1016/S2666-5247(21)00266-4 10.1016/j.cell.2020.10.052 10.1038/s41586-020-2608-y 10.1038/s41586-021-03681-2 10.1126/science.abm0829 10.1126/science.1256427 10.1126/sciimmunol.abj1750 10.1038/s41586-021-04386-2 10.1038/s41467-021-21118-2 10.1038/s41586-020-2852-1 10.1038/nm.3443 10.1126/science.abd0827 10.1016/j.xcrm.2020.100040 10.1016/j.immuni.2021.08.013 10.1126/scitranslmed.abm3302 10.1016/j.cell.2021.02.026 10.1016/j.xcrm.2022.100529 10.1016/j.vaccine.2004.11.075 10.1038/s41586-020-2895-3 10.1016/j.cell.2020.08.012 10.1038/s41586-021-04245-0 10.1016/j.cell.2018.07.033 10.1016/j.chom.2020.04.004 10.1016/j.immuni.2020.07.020 10.1016/j.xcrm.2021.100255 10.1073/pnas.2106535118 10.1016/j.chom.2020.06.021 10.1172/jci.insight.142032 10.1126/scitranslmed.abi4547 10.1038/s41591-020-0913-5 10.1371/journal.pbio.3001284 10.1126/science.abd3871 10.1016/j.cell.2020.05.015 10.1038/s41586-020-03041-6 10.1016/j.xcrm.2021.100355 10.1016/j.cell.2020.05.042 10.1038/s41586-020-2342-5 10.1038/nri.2017.106 10.1038/s41591-021-01377-8 10.1002/cpim.116 10.1038/s41467-020-17892-0 10.1038/s41591-021-01294-w 10.1016/j.cell.2020.06.010 10.1038/s41467-021-26178-y 10.1038/s41467-021-26239-2 10.1038/s41586-022-04441-6 10.1128/Spectrum.01803-21 10.1016/j.chom.2021.05.012 10.1038/s41467-020-20653-8 10.1016/j.cell.2022.01.015 10.1128/JVI.01110-21 10.1038/s41586-021-03275-y 10.1056/NEJMc2119912 10.1128/mBio.03617-20 10.1128/JVI.01696-18 10.1073/pnas.1221555110 10.1371/journal.ppat.1009758 10.1126/science.1069660 10.1016/j.cell.2021.06.005 10.1038/s41467-020-19891-7 10.1038/s41586-020-2798-3 10.1001/jama.2021.2294 10.1128/JVI.01164-14 10.1126/science.abj0299 10.1016/j.chom.2021.02.020 10.1038/s41586-020-2607-z 10.1038/s41591-021-01270-4 10.1038/s41586-021-04017-w 10.1038/s41586-020-2622-0 10.1016/j.celrep.2021.109400 10.1126/science.abl8912 10.1371/journal.pone.0247640 10.1371/journal.ppat.1005578 10.1016/j.celrep.2020.107940 10.1016/j.cell.2021.12.002 10.1016/j.cell.2021.05.040 10.1126/sciadv.abg7996 10.1126/science.abj4176 10.1038/s41590-021-01021-0 10.1016/j.vaccine.2020.10.064 10.1073/pnas.2009799117 10.1038/s41590-020-0778-2 10.1016/j.chom.2021.04.007 10.1128/mSphere.00159-21 10.1001/jama.2021.3341 10.1016/j.ebiom.2021.103626 10.1126/science.1097211 10.1371/journal.pone.0248348 10.1126/science.abf9302 10.1126/science.abd7728 10.4269/ajtmh.20-0762 10.1016/j.cell.2020.06.043 10.1128/mBio.02749-21 10.1016/j.chom.2021.02.003 10.1038/s41586-020-2787-6 10.1016/j.xcrm.2021.100354 10.1016/j.xcrm.2021.100405 10.1016/j.chom.2016.05.014 10.1126/scitranslmed.abn9243 10.1101/2022.01.03.22268599 10.1126/scitranslmed.abm2311 10.1101/2021.01.19.21249592 10.1101/2021.09.07.21263228 10.1016/j.celrep.2022.110829 |
| ContentType | Journal Article |
| Copyright | Springer Nature Limited 2022 2022. Springer Nature Limited. Copyright Nature Publishing Group May 26, 2022 Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: Springer Nature Limited 2022 – notice: 2022. Springer Nature Limited. – notice: Copyright Nature Publishing Group May 26, 2022 – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QG 7QL 7QP 7QR 7RV 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7X2 7X7 7XB 88A 88E 88G 88I 8AF 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK 8G5 ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BEC BENPR BGLVJ BHPHI BKSAR C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M2M M2O M2P M7N M7P M7S MBDVC NAPCQ P5Z P62 P64 PATMY PCBAR PDBOC PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ PTHSS PYCSY Q9U R05 RC3 S0X SOI 7X8 1XC 5PM |
| DOI | 10.1038/s41586-022-04690-5 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Meteorological & Geoastrophysical Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection eLibrary Curriculum ProQuest Central Technology Collection Natural Science Collection Earth, Atmospheric & Aquatic Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database Health & Medical Collection (Alumni) Medical Database Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database ProQuest Engineering Database Research Library (Corporate) Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database ProQuest Earth, Atmospheric & Aquatic Science Database (NC LIVE) Materials Science Collection ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology Engineering collection Environmental Science Collection ProQuest Central Basic University of Michigan Genetics Abstracts SIRS Editorial Environment Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Earth, Atmospheric & Aquatic Science Database Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) University of Michigan Technology Collection Technology Research Database ProQuest One Academic Middle East (New) SIRS Editorial Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central Earth, Atmospheric & Aquatic Science Collection ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Research Library ProQuest Materials Science Collection ProQuest Public Health ProQuest Central Basic ProQuest Science Journals ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library ProQuest Psychology Journals Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Agricultural Science Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Physics Public Health |
| EISSN | 1476-4687 |
| EndPage | 652 |
| ExternalDocumentID | PMC9345323 oai_HAL_hal_04794622v1 35361968 10_1038_s41586_022_04690_5 |
| Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, N.I.H., Intramural Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GrantInformation_xml | – fundername: NIAID NIH HHS grantid: U19 AI057266 – fundername: NIAID NIH HHS grantid: 75N93019C00076 – fundername: NIAID NIH HHS grantid: 75N93019C00052 – fundername: NIAID NIH HHS grantid: 75N93021C00017 – fundername: NIAID NIH HHS grantid: R01 AI143639 – fundername: Howard Hughes Medical Institute – fundername: NIAID NIH HHS grantid: 75N93021C00014 – fundername: NIAID NIH HHS grantid: P01 AI158571 – fundername: Intramural NIH HHS grantid: ZIA AI005156 – fundername: NIAID NIH HHS grantid: R24 AI120942 |
| GroupedDBID | --- --Z -DZ -ET -~X .55 .CO .XZ 07C 0R~ 0WA 123 186 1OL 1VR 29M 2KS 2XV 39C 41X 53G 5RE 6TJ 70F 7RV 7X2 7X7 7XC 85S 88A 88E 88I 8AF 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ 8G5 8R4 8R5 8WZ 97F 97L A6W A7Z AAEEF AAHBH AAHTB AAIKC AAKAB AAMNW AASDW AAYEP AAYZH AAZLF ABDQB ABFSI ABIVO ABJCF ABJNI ABLJU ABOCM ABPEJ ABPPZ ABUWG ABWJO ABZEH ACBEA ACBWK ACGFO ACGFS ACGOD ACIWK ACKOT ACMJI ACNCT ACPRK ACWUS ADBBV ADFRT ADUKH AENEX AEUYN AFBBN AFFNX AFKRA AFLOW AFRAH AFSHS AGAYW AGHSJ AGHTU AGOIJ AGSOS AHMBA AHSBF AIDUJ ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARAPS ARMCB ASPBG ATCPS ATWCN AVWKF AXYYD AZFZN AZQEC BBNVY BCU BEC BENPR BGLVJ BHPHI BIN BKEYQ BKKNO BKSAR BPHCQ BVXVI CCPQU CJ0 CS3 D1I D1J D1K DU5 DWQXO E.- E.L EAP EBS EE. EMH EPS EX3 EXGXG F5P FAC FEDTE FQGFK FSGXE FYUFA GNUQQ GUQSH HCIFZ HG6 HMCUK HVGLF HZ~ IAO ICQ IEA IEP IGS IH2 IHR INH INR IOF IPY ISR K6- KB. KOO L6V L7B LK5 LK8 LSO M0K M1P M2M M2O M2P M7P M7R M7S N9A NAPCQ NEPJS O9- OBC OES OHH OMK OVD P2P P62 PATMY PCBAR PDBOC PKN PQQKQ PROAC PSQYO PSYQQ PTHSS PYCSY Q2X R05 RND RNS RNT RNTTT RXW S0X SC5 SHXYY SIXXV SJFOW SJN SNYQT SOJ TAE TAOOD TBHMF TDRGL TEORI TN5 TSG TWZ U5U UIG UKHRP UKR UMD UQL VQA VVN WH7 WOW X7M XIH XKW XZL Y6R YAE YCJ YFH YIF YIN YNT YOC YQT YR2 YR5 YXB YZZ Z5M ZCA ~02 ~7V ~88 ~KM AARCD AAYXX ABFSG ACMFV ACSTC AEZWR AFANA AFHIU AHWEU AIXLP ALPWD ATHPR CITATION PHGZM PHGZT .-4 .GJ .HR 00M 08P 1CY 1VW 354 3EH 3O- 4.4 41~ 42X 4R4 663 79B 9M8 A8Z AAJYS AAKAS AAVBQ ABAWZ ABDBF ABDPE ABEFU ABNNU ACBNA ACBTR ACRPL ACTDY ACUHS ADGHP ADNMO ADRHT ADXHL ADYSU ADZCM AETEA AFFDN AFHKK AGCDD AGGDT AGNAY AGQPQ AIDAL AIYXT AJUXI APEBS ARTTT B0M BCR BDKGC BES BKOMP BLC CGR CUY CVF DB5 DO4 EAD EAS EAZ EBC EBD EBO ECC ECM EIF EJD EMB EMF EMK EMOBN EPL ESE ESN ESX FA8 I-F ITC J5H L-9 LGEZI LOTEE MVM N4W NADUK NEJ NFIDA NPM NXXTH ODYON OHT P-O PEA PJZUB PM3 PPXIY PQGLB PV9 QS- R4F RHI SKT SV3 TH9 TUD TUS UBY UHB USG VOH X7L XOL YJ6 YQI YQJ YV5 YXA YYP YYQ ZCG ZE2 ZGI ZHY ZKB ZY4 ~8M ~G0 3V. 7QG 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7TG 7TK 7TM 7TO 7U9 7XB 8FD 8FK AFKWF C1K FR3 H94 K9. KL. M7N MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U RC3 SOI 7X8 1XC UMC 5PM |
| ID | FETCH-LOGICAL-c508t-244fd2d99d55c1cd32e00d654c201cd57c06a916a780d35907981db80396a8da3 |
| IEDL.DBID | 8FG |
| ISSN | 0028-0836 1476-4687 |
| IngestDate | Thu Aug 21 18:38:37 EDT 2025 Fri May 09 12:20:23 EDT 2025 Thu Jul 10 23:59:38 EDT 2025 Sat Aug 23 12:50:25 EDT 2025 Mon Jul 21 06:03:35 EDT 2025 Tue Jul 01 02:32:34 EDT 2025 Thu Apr 24 22:59:33 EDT 2025 Fri Feb 21 02:39:12 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7911 |
| Keywords | Variants of concern SARS-CoV-2 |
| Language | English |
| License | 2022. Springer Nature Limited. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c508t-244fd2d99d55c1cd32e00d654c201cd57c06a916a780d35907981db80396a8da3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 M.M.D, E.G, M.B.F, F.K, A.G, N.J.S, A.S, P.G.T, D.J.S, M.S.D, D.J.P, M.S.S- writing of the initial draft, A.A, G.A, R.R.A, R.S.B, D.H.B, J.D.B, L.B, G.B, A.C.M.B, E.A.B, D.L.B, T.L.B, L.B, W.J.B, J.M.C, L.C-L, T.L.D, M.E.D-G, B.L.D, H.D, M.D, N.A.D-R, D.C.D, C.D, V-V.E, A.E, T.P.F, G.F, W.C.F, R.A.M.F, J.F, A.G-S, A.G, A.S.G-R, A.G, B.L.H, P.J.H, D.D.H, M.R.H, Y.H, S.L.J, L.J, T.J, R.M.J, T.C.J, A.J, Y.K, L.K, M.P.G.K, B.K, E.K, R.A.K, E.B.L, J.E.L, M.J.L, Z.L, B.L, J.P.L, Y.L, A.B.M, M.J.M, V.A. M, V.D.M, D.C.M, B.M, V.J.M, J.E.M, M.S.N, A.N, A.M.N, S.O, A.P, S.P, M.C.P, B.R, M.R, P.W.R, S.S, R.H.S, S.D.S, M.S, S.S-C, R.A.S, M.S, A.S, R.S.S, X.S, P-Y.S, M.S, V.S, S.S, L.B.T, J.T, S.T, S.T, S.A.T, M.A.V, H.V.B, L.A.V, L.R.V, Z.S.W, L.W, M.W, P.W, W.W, S.C.W, R.J.W, C.D.W, D.E.W, S.M.W, S.P.J.W, B.M.W, S.H.W, X.X, B.Y, H.Y, B.Z, T.H, M.M.D, E.G, M.B.F, F.K, A.G, N.J.S, A.S, P.G.T, D.J.S, M.S.D, D.J.P, M.S.S-input, concept, editing and revisions Author Contributions Contributed equally |
| ORCID | 0000-0001-6652-0701 0000-0001-8803-7606 0000-0002-6969-1167 0000-0001-9262-1813 0000-0002-4700-8224 0000-0003-3272-3484 0000-0001-6300-0452 0000-0003-3248-1761 0000-0002-8791-3165 0000-0003-0918-016X 0000-0002-1976-7688 0000-0002-9352-7877 0000-0002-5204-2312 0000-0002-7410-9741 0000-0003-0237-501X 0000-0002-6129-2532 0000-0002-6551-1827 0000-0002-2026-5757 0000-0001-5553-1616 0000-0001-7955-0256 0000-0001-8198-0976 0000-0002-9380-6569 0000-0002-2209-5966 0000-0001-8034-2382 0000-0002-5286-5693 0000-0002-6416-5096 0000-0002-7680-9215 0000-0001-6221-2015 0000-0002-5994-3957 0000-0002-2686-8380 0000-0002-5822-5558 0000-0003-3277-8792 0000-0002-8922-8946 0000-0002-2021-727X 0000-0002-4397-7132 0000-0003-1120-9531 0000-0002-2425-852X 0000-0001-6827-8701 0000-0002-0561-1578 0000-0002-1376-6916 0000-0002-2393-1890 0000-0003-4213-2354 0000-0002-1515-725X 0000-0001-5061-8296 0000-0003-1564-8590 0000-0003-3133-0849 0000-0002-0710-9514 0000-0002-5190-980X 0000-0002-0824-2667 0000-0003-3156-3132 0000-0001-7923-0519 0000-0003-0616-9117 0000-0003-3583-4497 0000-0003-2454-7652 0000-0001-9321-7839 0000-0003-1355-892X 0000-0003-4121-776X 0000-0002-5648-3190 0000-0002-0941-4467 0000-0001-5127-4659 0000-0002-8960-0728 0000-0002-6675-6359 0000-0003-1627-149X 0000-0002-9965-1289 0000-0001-7342-9295 0000-0003-1442-9177 0000-0001-6909-4779 0000-0003-3890-9116 0000-0002-6309-6797 0000-0001-8016-8556 0000-0001-9840-2953 0000-0003-0107-0775 0000-0003-3653-4592 0000-0001-6270-1644 0000-0003-2463-027X 0000-0003-3650-8490 0000-0001-8095-2869 0000-0002-2288-3196 0000-0002-3344-9096 0000-0003-1267-3408 0000-0003-4914-8228 0000-0003-4595-0651 |
| OpenAccessLink | https://www.nature.com/articles/s41586-022-04690-5.pdf |
| PMID | 35361968 |
| PQID | 2670682016 |
| PQPubID | 40569 |
| PageCount | 13 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9345323 hal_primary_oai_HAL_hal_04794622v1 proquest_miscellaneous_2646724564 proquest_journals_2670682016 pubmed_primary_35361968 crossref_citationtrail_10_1038_s41586_022_04690_5 crossref_primary_10_1038_s41586_022_04690_5 springer_journals_10_1038_s41586_022_04690_5 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-05-26 |
| PublicationDateYYYYMMDD | 2022-05-26 |
| PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-26 day: 26 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationSubtitle | International weekly journal of science |
| PublicationTitle | Nature (London) |
| PublicationTitleAbbrev | Nature |
| PublicationTitleAlternate | Nature |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
| References | Starr (CR20) 2021; 371 Yamin (CR60) 2021; 599 Vanderheiden (CR28) 2020; 131 Bricker (CR101) 2021; 36 Asthagiri Arunkumar (CR46) 2019; 93 Jansen, Retpen (CR9) 1988; 154 Pajon (CR116) 2022; 386 Tso (CR53) 2021; 16 Halfmann (CR106) 2022; 603 Khoury (CR27) 2021; 27 McCray (CR88) 2007; 81 Zhou (CR114) 2005; 23 Boras (CR83) 2021; 12 Barnes (CR17) 2020; 588 van Doremalen (CR107) 2021; 13 Escalera (CR15) 2022; 30 Sun (CR89) 2020; 182 Gartland (CR70) 2014; 88 Xie (CR24) 2020; 27 Moore (CR68) 2002; 296 Sia (CR102) 2020; 583 Saadat (CR34) 2021; 325 Mateus (CR62) 2020; 370 Henry Dunand (CR71) 2016; 19 CR42 Begin (CR57) 2021; 27 Gagne (CR112) 2022; 185 Liu (CR118) 2022; 602 Walensky, Walke, Fauci (CR3) 2021; 325 Tian (CR80) 2021; 12 Korber (CR5) 2020; 182 Muruato (CR97) 2021; 19 Pino (CR12) 2021; 6 Fischer (CR4) 2021; 29 Vanderheiden (CR96) 2021; 12 Greaney (CR19) 2021; 29 Tarke (CR119) 2022; 185 Fonville (CR36) 2014; 346 Sun (CR90) 2021; 17 Knezevic (CR75) 2021; 3 Dan (CR64) 2021; 371 Corbett (CR111) 2021; 22 Zheng (CR95) 2021; 589 Vogel (CR77) 2021; 592 Plante (CR2) 2021; 29 Liu (CR25) 2022; 602 Goel (CR65) 2021; 374 Hou (CR32) 2020; 182 Jegaskanda, Weinfurter, Friedrich, Kent (CR73) 2013; 87 Bewley (CR113) 2021; 7 Neerukonda (CR11) 2021; 16 Smith (CR37) 2004; 305 Roubidoux (CR45) 2021; 12 Guebre-Xabier (CR79) 2020; 38 CR61 Ying (CR99) 2021; 14 Carreno (CR8) 2021; 73 Case (CR33) 2020; 28 Atyeo (CR51) 2020; 53 Alter (CR67) 2021; 596 Tan (CR72) 2016; 12 Zohar (CR50) 2020; 183 Tarke (CR6) 2021; 2 Hansen (CR82) 2020; 369 Imai (CR100) 2020; 117 Cameroni (CR115) 2022; 602 Suthar (CR40) 2020; 1 Geers (CR66) 2021; 6 Amanat (CR39) 2020; 26 He (CR84) 2021; 184 Starr (CR21) 2020; 182 Davis (CR23) 2021; 9 Corbett (CR30) 2021; 374 Saphire (CR47) 2018; 174 Lu, Suscovich, Fortune, Alter (CR49) 2018; 18 Imai (CR103) 2021; 118 Stadlbauer (CR44) 2020; 57 Anand (CR52) 2021; 2 Munoz-Fontela (CR86) 2020; 586 Carreno (CR122) 2022; 602 Fischer (CR108) 2021; 12 CR120 CR121 Mercado (CR55) 2020; 586 McMahan (CR54) 2021; 590 Grifoni (CR63) 2020; 181 Plante (CR105) 2021; 592 Winkler (CR92) 2020; 21 Hertz (CR69) 2013; 110 Krammer (CR1) 2020; 586 Chen (CR31) 2021; 27 CR16 Schafer (CR59) 2021; 218 CR14 Pruijssers (CR81) 2020; 32 CR13 DiLillo, Tan, Palese, Ravetch (CR48) 2014; 20 Plante (CR74) 2020; 592 CR98 Wang (CR29) 2021; 29 Schmitz (CR104) 2021; 54 Ozono (CR87) 2021; 12 Francica (CR109) 2021; 13 Pegu (CR7) 2021; 373 Corbett (CR76) 2020; 586 Starr, Greaney, Dingens, Bloom (CR18) 2021; 2 Lusvarghi (CR10) 2021; 96 Amanat (CR43) 2021; 184 Winkler (CR58) 2021; 184 Golden (CR93) 2020; 5 Moreau (CR94) 2020; 103 Cohen (CR41) 2021; 2 Hirose (CR85) 2021; 6 CR22 Wajnberg (CR38) 2020; 370 Corbett (CR110) 2021; 373 Edara (CR117) 2022; 3 Xie (CR26) 2021; 27 van Doremalen (CR78) 2020; 586 Oladunni (CR91) 2020; 11 Muruato (CR35) 2020; 11 Gorman (CR56) 2021; 2 M Imai (4690_CR100) 2020; 117 B Korber (4690_CR5) 2020; 182 JA Plante (4690_CR105) 2021; 592 V-V Edara (4690_CR117) 2022; 3 JH Tian (4690_CR80) 2021; 12 JA Plante (4690_CR2) 2021; 29 R Yamin (4690_CR60) 2021; 599 N van Doremalen (4690_CR107) 2021; 13 R Hirose (4690_CR85) 2021; 6 B Ying (4690_CR99) 2021; 14 A Vanderheiden (4690_CR28) 2020; 131 SF Sia (4690_CR102) 2020; 583 P Wang (4690_CR29) 2021; 29 A Grifoni (4690_CR63) 2020; 181 JM Fonville (4690_CR36) 2014; 346 4690_CR121 JA Plante (4690_CR74) 2020; 592 4690_CR120 AJ Pruijssers (4690_CR81) 2020; 32 M Gagne (4690_CR112) 2022; 185 CB Moore (4690_CR68) 2002; 296 DJ DiLillo (4690_CR48) 2014; 20 JM Dan (4690_CR64) 2021; 371 A Tarke (4690_CR119) 2022; 185 T Zohar (4690_CR50) 2020; 183 4690_CR61 W Fischer (4690_CR4) 2021; 29 R Pajon (4690_CR116) 2022; 386 A Tarke (4690_CR6) 2021; 2 Y Liu (4690_CR25) 2022; 602 FS Oladunni (4690_CR91) 2020; 11 KS Corbett (4690_CR30) 2021; 374 S Saadat (4690_CR34) 2021; 325 N van Doremalen (4690_CR78) 2020; 586 E Cameroni (4690_CR115) 2022; 602 A Wajnberg (4690_CR38) 2020; 370 SP Anand (4690_CR52) 2021; 2 M Guebre-Xabier (4690_CR79) 2020; 38 J Mateus (4690_CR62) 2020; 370 JE Jansen (4690_CR9) 1988; 154 A Pegu (4690_CR7) 2021; 373 P Begin (4690_CR57) 2021; 27 CO Barnes (4690_CR17) 2020; 588 AE Muruato (4690_CR35) 2020; 11 RP Walensky (4690_CR3) 2021; 325 GS Tan (4690_CR72) 2016; 12 M Pino (4690_CR12) 2021; 6 FY Tso (4690_CR53) 2021; 16 CJ Henry Dunand (4690_CR71) 2016; 19 4690_CR42 KS Corbett (4690_CR111) 2021; 22 LL Lu (4690_CR49) 2018; 18 DS Khoury (4690_CR27) 2021; 27 A Schafer (4690_CR59) 2021; 218 MJ Gorman (4690_CR56) 2021; 2 S Lusvarghi (4690_CR10) 2021; 96 MS Suthar (4690_CR40) 2020; 1 AJ Greaney (4690_CR19) 2021; 29 X Xie (4690_CR26) 2021; 27 ES Winkler (4690_CR58) 2021; 184 ES Winkler (4690_CR92) 2020; 21 D Geers (4690_CR66) 2021; 6 L Liu (4690_CR118) 2022; 602 JJ Davis (4690_CR23) 2021; 9 DJ Smith (4690_CR37) 2004; 305 RR Goel (4690_CR65) 2021; 374 YJ Hou (4690_CR32) 2020; 182 D Stadlbauer (4690_CR44) 2020; 57 KW Cohen (4690_CR41) 2021; 2 C Munoz-Fontela (4690_CR86) 2020; 586 RJ Fischer (4690_CR108) 2021; 12 KS Corbett (4690_CR76) 2020; 586 CP Sun (4690_CR90) 2021; 17 SN Neerukonda (4690_CR11) 2021; 16 J Sun (4690_CR89) 2020; 182 JM Carreno (4690_CR122) 2022; 602 X Xie (4690_CR24) 2020; 27 NB Mercado (4690_CR55) 2020; 586 4690_CR22 K McMahan (4690_CR54) 2021; 590 G Alter (4690_CR67) 2021; 596 TN Starr (4690_CR18) 2021; 2 S Ozono (4690_CR87) 2021; 12 A Escalera (4690_CR15) 2022; 30 TN Starr (4690_CR20) 2021; 371 C Atyeo (4690_CR51) 2020; 53 JR Francica (4690_CR109) 2021; 13 RE Chen (4690_CR31) 2021; 27 KR Bewley (4690_CR113) 2021; 7 I Knezevic (4690_CR75) 2021; 3 A Vanderheiden (4690_CR96) 2021; 12 A Muruato (4690_CR97) 2021; 19 EO Saphire (4690_CR47) 2018; 174 X He (4690_CR84) 2021; 184 4690_CR14 4690_CR16 4690_CR98 TL Bricker (4690_CR101) 2021; 36 4690_CR13 GB Moreau (4690_CR94) 2020; 103 TN Starr (4690_CR21) 2020; 182 B Boras (4690_CR83) 2021; 12 S Jegaskanda (4690_CR73) 2013; 87 J Hansen (4690_CR82) 2020; 369 G Asthagiri Arunkumar (4690_CR46) 2019; 93 T Hertz (4690_CR69) 2013; 110 J Zheng (4690_CR95) 2021; 589 AJ Schmitz (4690_CR104) 2021; 54 PJ Halfmann (4690_CR106) 2022; 603 J Zhou (4690_CR114) 2005; 23 AB Vogel (4690_CR77) 2021; 592 EK Roubidoux (4690_CR45) 2021; 12 KS Corbett (4690_CR110) 2021; 373 PB McCray Jr (4690_CR88) 2007; 81 F Amanat (4690_CR43) 2021; 184 AJ Gartland (4690_CR70) 2014; 88 JB Case (4690_CR33) 2020; 28 JM Carreno (4690_CR8) 2021; 73 F Amanat (4690_CR39) 2020; 26 F Krammer (4690_CR1) 2020; 586 JW Golden (4690_CR93) 2020; 5 M Imai (4690_CR103) 2021; 118 |
| References_xml | – volume: 6 start-page: eabh3634 year: 2021 ident: CR12 article-title: A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abh3634 – ident: CR22 – volume: 27 start-page: 2012 year: 2021 end-page: 2024 ident: CR57 article-title: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial publication-title: Nat. Med. doi: 10.1038/s41591-021-01488-2 – volume: 218 start-page: e20201993 year: 2021 ident: CR59 article-title: Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo publication-title: J. Exp. Med. doi: 10.1084/jem.20201993 – volume: 589 start-page: 603 year: 2021 end-page: 607 ident: CR95 article-title: COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice publication-title: Nature doi: 10.1038/s41586-020-2943-z – volume: 30 start-page: 373 year: 2022 end-page: 387 ident: CR15 article-title: Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission publication-title: Cell Host Microbe doi: 10.1016/j.chom.2022.01.006 – volume: 57 start-page: e100 year: 2020 ident: CR44 article-title: SARS-CoV-2 seroconversion in humans: a detailed protocol for a serological assay, antigen production, and test setup publication-title: Curr. Protoc. Microbiol. doi: 10.1002/cpmc.100 – volume: 371 start-page: eabf4063 year: 2021 ident: CR64 article-title: Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection publication-title: Science doi: 10.1126/science.abf4063 – volume: 13 start-page: eabh0755 year: 2021 ident: CR107 article-title: Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abh0755 – ident: CR16 – volume: 87 start-page: 5512 year: 2013 end-page: 5522 ident: CR73 article-title: Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques publication-title: J. Virol. doi: 10.1128/JVI.03030-12 – ident: CR121 – ident: CR42 – volume: 81 start-page: 813 year: 2007 end-page: 821 ident: CR88 article-title: Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus publication-title: J. Virol. doi: 10.1128/JVI.02012-06 – volume: 602 start-page: 682 year: 2022 end-page: 688 ident: CR122 article-title: Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron publication-title: Nature doi: 10.1038/s41586-022-04399-5 – volume: 602 start-page: 676 year: 2022 end-page: 681 ident: CR118 article-title: Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2 publication-title: Nature doi: 10.1038/s41586-021-04388-0 – volume: 2 start-page: 100290 year: 2021 ident: CR52 article-title: Longitudinal analysis of humoral immunity against SARS-CoV-2 spike in convalescent individuals up to 8 months post-symptom onset publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100290 – volume: 3 start-page: e235 year: 2021 end-page: e240 ident: CR75 article-title: WHO international standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community publication-title: Lancet Microbe doi: 10.1016/S2666-5247(21)00266-4 – volume: 183 start-page: 1508 year: 2020 end-page: 1519 ident: CR50 article-title: Compromised humoral functional evolution tracks with SARS-CoV-2 mortality publication-title: Cell doi: 10.1016/j.cell.2020.10.052 – volume: 586 start-page: 578 year: 2020 end-page: 582 ident: CR78 article-title: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques publication-title: Nature doi: 10.1038/s41586-020-2608-y – volume: 596 start-page: 268 year: 2021 end-page: 272 ident: CR67 article-title: Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans publication-title: Nature doi: 10.1038/s41586-021-03681-2 – volume: 374 start-page: eabm0829 year: 2021 ident: CR65 article-title: mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern publication-title: Science doi: 10.1126/science.abm0829 – volume: 346 start-page: 996 year: 2014 end-page: 1000 ident: CR36 article-title: Antibody landscapes after influenza virus infection or vaccination publication-title: Science doi: 10.1126/science.1256427 – volume: 6 start-page: eabj1750 year: 2021 ident: CR66 article-title: SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abj1750 – volume: 602 start-page: 664 year: 2022 end-page: 670 ident: CR115 article-title: Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift publication-title: Nature doi: 10.1038/s41586-021-04386-2 – volume: 12 year: 2021 ident: CR87 article-title: SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity publication-title: Nat. Commun. doi: 10.1038/s41467-021-21118-2 – volume: 588 start-page: 682 year: 2020 end-page: 687 ident: CR17 article-title: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies publication-title: Nature doi: 10.1038/s41586-020-2852-1 – volume: 20 start-page: 143 year: 2014 end-page: 151 ident: CR48 article-title: Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo publication-title: Nat. Med. doi: 10.1038/nm.3443 – volume: 369 start-page: 1010 year: 2020 end-page: 1014 ident: CR82 article-title: Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail publication-title: Science doi: 10.1126/science.abd0827 – volume: 1 start-page: 100040 year: 2020 ident: CR40 article-title: Rapid generation of neutralizing antibody responses in COVID-19 patients publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2020.100040 – volume: 54 start-page: 2159 year: 2021 end-page: 2166 ident: CR104 article-title: A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants publication-title: Immunity doi: 10.1016/j.immuni.2021.08.013 – volume: 14 start-page: eabm3302 year: 2021 ident: CR99 article-title: Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abm3302 – volume: 184 start-page: 1804 year: 2021 end-page: 1820 ident: CR58 article-title: Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection publication-title: Cell doi: 10.1016/j.cell.2021.02.026 – volume: 3 start-page: 100529 year: 2022 ident: CR117 article-title: mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2022.100529 – volume: 23 start-page: 3202 year: 2005 end-page: 3209 ident: CR114 article-title: Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys publication-title: Vaccine doi: 10.1016/j.vaccine.2004.11.075 – volume: 592 start-page: 116 year: 2020 end-page: 121 ident: CR74 article-title: Spike mutation D614G alters SARS-CoV-2 fitness publication-title: Nature doi: 10.1038/s41586-020-2895-3 – volume: 182 start-page: 1295 year: 2020 end-page: 1310 ident: CR21 article-title: Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding publication-title: Cell doi: 10.1016/j.cell.2020.08.012 – volume: 602 start-page: 294 year: 2022 end-page: 299 ident: CR25 article-title: The N501Y spike substitution enhances SARS-CoV-2 infection and transmission publication-title: Nature doi: 10.1038/s41586-021-04245-0 – volume: 174 start-page: 938 year: 2018 end-page: 952 ident: CR47 article-title: Systematic analysis of monoclonal antibodies against ebola virus GP defines features that contribute to protection publication-title: Cell doi: 10.1016/j.cell.2018.07.033 – volume: 27 start-page: 841 year: 2020 end-page: 848 ident: CR24 article-title: An infectious cDNA clone of SARS-CoV-2 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.04.004 – volume: 53 start-page: 524 year: 2020 end-page: 532 ident: CR51 article-title: Distinct early serological signatures track with SARS-CoV-2 survival publication-title: Immunity doi: 10.1016/j.immuni.2020.07.020 – volume: 2 start-page: 100255 year: 2021 ident: CR18 article-title: Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100255 – volume: 118 start-page: e2106535118 year: 2021 ident: CR103 article-title: Characterization of a new SARS-CoV-2 variant that emerged in Brazil publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2106535118 – volume: 28 start-page: 475 year: 2020 end-page: 485 ident: CR33 article-title: Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.06.021 – volume: 5 start-page: e142032 year: 2020 ident: CR93 article-title: Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease publication-title: JCI Insight doi: 10.1172/jci.insight.142032 – volume: 13 start-page: eabi4547 year: 2021 ident: CR109 article-title: Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abi4547 – volume: 26 start-page: 1033 year: 2020 end-page: 1036 ident: CR39 article-title: A serological assay to detect SARS-CoV-2 seroconversion in humans publication-title: Nat. Med. doi: 10.1038/s41591-020-0913-5 – volume: 19 start-page: e3001284 year: 2021 ident: CR97 article-title: Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge publication-title: PLoS Biol. doi: 10.1371/journal.pbio.3001284 – volume: 370 start-page: 89 year: 2020 end-page: 94 ident: CR62 article-title: Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans publication-title: Science doi: 10.1126/science.abd3871 – volume: 181 start-page: 1489 year: 2020 end-page: 1501 ident: CR63 article-title: Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals publication-title: Cell doi: 10.1016/j.cell.2020.05.015 – volume: 590 start-page: 630 year: 2021 end-page: 634 ident: CR54 article-title: Correlates of protection against SARS-CoV-2 in rhesus macaques publication-title: Nature doi: 10.1038/s41586-020-03041-6 – volume: 2 start-page: 100355 year: 2021 ident: CR6 article-title: Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100355 – ident: CR13 – volume: 182 start-page: 429 year: 2020 end-page: 446 ident: CR32 article-title: SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract publication-title: Cell doi: 10.1016/j.cell.2020.05.042 – volume: 583 start-page: 834 year: 2020 end-page: 838 ident: CR102 article-title: Pathogenesis and transmission of SARS-CoV-2 in golden hamsters publication-title: Nature doi: 10.1038/s41586-020-2342-5 – ident: CR120 – volume: 18 start-page: 46 year: 2018 end-page: 61 ident: CR49 article-title: Beyond binding: antibody effector functions in infectious diseases publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2017.106 – volume: 27 start-page: 1205 year: 2021 end-page: 1211 ident: CR27 article-title: Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection publication-title: Nat. Med. doi: 10.1038/s41591-021-01377-8 – volume: 131 start-page: e116 year: 2020 ident: CR28 article-title: Development of a rapid focus reduction neutralization test assay for measuring SARS-CoV-2 neutralizing antibodies publication-title: Curr. Protoc. Immunol. doi: 10.1002/cpim.116 – volume: 11 year: 2020 ident: CR35 article-title: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation publication-title: Nat. Commun. doi: 10.1038/s41467-020-17892-0 – volume: 27 start-page: 717 year: 2021 end-page: 726 ident: CR31 article-title: Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies publication-title: Nat. Med. doi: 10.1038/s41591-021-01294-w – volume: 182 start-page: 734 year: 2020 end-page: 743 ident: CR89 article-title: Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment publication-title: Cell doi: 10.1016/j.cell.2020.06.010 – volume: 12 year: 2021 ident: CR108 article-title: ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 publication-title: Nat. Commun. doi: 10.1038/s41467-021-26178-y – volume: 12 year: 2021 ident: CR83 article-title: Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19 publication-title: Nat. Commun. doi: 10.1038/s41467-021-26239-2 – volume: 603 start-page: 687 year: 2022 end-page: 692 ident: CR106 article-title: SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters publication-title: Nature doi: 10.1038/s41586-022-04441-6 – volume: 9 start-page: e0180321 year: 2021 ident: CR23 article-title: Analysis of the ARTIC version 3 and version 4 SARS-CoV-2 primers and their impact on the detection of the G142D amino acid substitution in the spike protein publication-title: Microbiol. Spectr. doi: 10.1128/Spectrum.01803-21 – volume: 29 start-page: 1093 year: 2021 end-page: 1110 ident: CR4 article-title: HIV-1 and SARS-CoV-2: patterns in the evolution of two pandemic pathogens publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.05.012 – volume: 12 year: 2021 ident: CR80 article-title: SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice publication-title: Nat. Commun. doi: 10.1038/s41467-020-20653-8 – volume: 185 start-page: 847 year: 2022 end-page: 859 ident: CR119 article-title: SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron publication-title: Cell doi: 10.1016/j.cell.2022.01.015 – volume: 96 start-page: JVI0111021 year: 2021 ident: CR10 article-title: Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects publication-title: J. Virol. doi: 10.1128/JVI.01110-21 – ident: CR61 – volume: 592 start-page: 283 year: 2021 end-page: 289 ident: CR77 article-title: BNT162b vaccines protect rhesus macaques from SARS-CoV-2 publication-title: Nature doi: 10.1038/s41586-021-03275-y – volume: 386 start-page: 1088 year: 2022 end-page: 1091 ident: CR116 article-title: SARS-CoV-2 Omicron variant neutralization after mRNA-1273 booster vaccination publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2119912 – volume: 12 start-page: e03617 year: 2021 end-page: 20 ident: CR45 article-title: Mutations in the hemagglutinin stalk domain do not permit escape from a protective, stalk-based vaccine-induced immune response in the mouse model publication-title: mBio doi: 10.1128/mBio.03617-20 – volume: 93 start-page: e01696 year: 2019 end-page: 18 ident: CR46 article-title: Broadly cross-reactive, nonneutralizing antibodies against influenza b virus hemagglutinin demonstrate effector function-dependent protection against lethal viral challenge in mice publication-title: J. Virol. doi: 10.1128/JVI.01696-18 – volume: 110 start-page: 13492 year: 2013 end-page: 13497 ident: CR69 article-title: HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1221555110 – volume: 17 start-page: e1009758 year: 2021 ident: CR90 article-title: Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1009758 – volume: 592 start-page: 116 year: 2021 end-page: 121 ident: CR105 article-title: Spike mutation D614G alters SARS-CoV-2 fitness publication-title: Nature doi: 10.1038/s41586-020-2895-3 – volume: 296 start-page: 1439 year: 2002 end-page: 1443 ident: CR68 article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level publication-title: Science doi: 10.1126/science.1069660 – volume: 184 start-page: 3936 year: 2021 end-page: 3948 ident: CR43 article-title: SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 publication-title: Cell doi: 10.1016/j.cell.2021.06.005 – volume: 11 year: 2020 ident: CR91 article-title: Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice publication-title: Nat. Commun. doi: 10.1038/s41467-020-19891-7 – volume: 586 start-page: 516 year: 2020 end-page: 527 ident: CR1 article-title: SARS-CoV-2 vaccines in development publication-title: Nature doi: 10.1038/s41586-020-2798-3 – volume: 325 start-page: 1037 year: 2021 end-page: 1038 ident: CR3 article-title: SARS-CoV-2 variants of concern in the United States—challenges and opportunities publication-title: JAMA doi: 10.1001/jama.2021.2294 – volume: 88 start-page: 8242 year: 2014 end-page: 8255 ident: CR70 article-title: Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial publication-title: J. Virol. doi: 10.1128/JVI.01164-14 – volume: 373 start-page: eabj0299 year: 2021 ident: CR110 article-title: Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates publication-title: Science doi: 10.1126/science.abj0299 – volume: 29 start-page: 508 year: 2021 end-page: 515 ident: CR2 article-title: The variant gambit: COVID-19’s next move publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.02.020 – volume: 586 start-page: 583 year: 2020 end-page: 588 ident: CR55 article-title: Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques publication-title: Nature doi: 10.1038/s41586-020-2607-z – volume: 27 start-page: 620 year: 2021 end-page: 621 ident: CR26 article-title: Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera publication-title: Nat. Med. doi: 10.1038/s41591-021-01270-4 – volume: 599 start-page: 465 year: 2021 end-page: 470 ident: CR60 article-title: Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy publication-title: Nature doi: 10.1038/s41586-021-04017-w – volume: 586 start-page: 567 year: 2020 end-page: 571 ident: CR76 article-title: SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness publication-title: Nature doi: 10.1038/s41586-020-2622-0 – volume: 36 start-page: 109400 year: 2021 ident: CR101 article-title: A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.109400 – volume: 374 start-page: 1343–1353 year: 2021 ident: CR30 article-title: Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates publication-title: Science doi: 10.1126/science.abl8912 – volume: 16 start-page: e0247640 year: 2021 ident: CR53 article-title: Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma publication-title: PLoS ONE doi: 10.1371/journal.pone.0247640 – volume: 12 start-page: e1005578 year: 2016 ident: CR72 article-title: Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1005578 – ident: CR14 – volume: 32 start-page: 107940 year: 2020 ident: CR81 article-title: Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice publication-title: Cell Rep. doi: 10.1016/j.celrep.2020.107940 – volume: 185 start-page: 113 year: 2022 end-page: 130 ident: CR112 article-title: Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung publication-title: Cell doi: 10.1016/j.cell.2021.12.002 – volume: 184 start-page: 3467 year: 2021 end-page: 3473 ident: CR84 article-title: Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques publication-title: Cell doi: 10.1016/j.cell.2021.05.040 – volume: 7 start-page: eabg7996 year: 2021 ident: CR113 article-title: Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques publication-title: Sci. Adv. doi: 10.1126/sciadv.abg7996 – volume: 373 start-page: 1372 year: 2021 end-page: 1377 ident: CR7 article-title: Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants publication-title: Science doi: 10.1126/science.abj4176 – volume: 22 start-page: 1306 year: 2021 end-page: 1315 ident: CR111 article-title: mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates publication-title: Nat. Immunol. doi: 10.1038/s41590-021-01021-0 – ident: CR98 – volume: 38 start-page: 7892 year: 2020 end-page: 7896 ident: CR79 article-title: NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge publication-title: Vaccine doi: 10.1016/j.vaccine.2020.10.064 – volume: 117 start-page: 16587 year: 2020 end-page: 16595 ident: CR100 article-title: Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2009799117 – volume: 21 start-page: 1327 year: 2020 end-page: 1335 ident: CR92 article-title: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function publication-title: Nat. Immunol. doi: 10.1038/s41590-020-0778-2 – volume: 29 start-page: 747 year: 2021 end-page: 751 ident: CR29 article-title: Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.04.007 – volume: 6 start-page: e00159 year: 2021 end-page: 21 ident: CR85 article-title: A cytopathic effect-based tissue culture method for HCoV-OC43 titration using TMPRSS2-expressing VeroE6 cells publication-title: mSphere doi: 10.1128/mSphere.00159-21 – volume: 325 start-page: 1467 year: 2021 end-page: 1469 ident: CR34 article-title: Binding and neutralization antibody titers after a single vaccine dose in health care workers previously infected with SARS-CoV-2 publication-title: JAMA doi: 10.1001/jama.2021.3341 – volume: 73 start-page: 103626 year: 2021 ident: CR8 article-title: Evidence for retained spike-binding and neutralizing activity against emerging SARS-CoV-2 variants in serum of COVID-19 mRNA vaccine recipients publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103626 – volume: 154 start-page: 323 year: 1988 end-page: 324 ident: CR9 article-title: Acute spontaneous streptococcal myositis. Case report publication-title: Acta Chir. Scand. – volume: 305 start-page: 371 year: 2004 end-page: 376 ident: CR37 article-title: Mapping the antigenic and genetic evolution of influenza virus publication-title: Science doi: 10.1126/science.1097211 – volume: 16 start-page: e0248348 year: 2021 ident: CR11 article-title: Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2 publication-title: PLoS ONE doi: 10.1371/journal.pone.0248348 – volume: 371 start-page: 850 year: 2021 end-page: 854 ident: CR20 article-title: Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 publication-title: Science doi: 10.1126/science.abf9302 – volume: 370 start-page: 1227 year: 2020 end-page: 1230 ident: CR38 article-title: Robust neutralizing antibodies to SARS-CoV-2 infection persist for months publication-title: Science doi: 10.1126/science.abd7728 – volume: 103 start-page: 1215 year: 2020 end-page: 1219 ident: CR94 article-title: Evaluation of K18-hACE2 mice as a model of SARS-CoV-2 infection publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.20-0762 – volume: 182 start-page: 812 year: 2020 end-page: 827 ident: CR5 article-title: Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus publication-title: Cell doi: 10.1016/j.cell.2020.06.043 – volume: 12 start-page: e0274921 year: 2021 ident: CR96 article-title: CCR2 signaling restricts SARS-CoV-2 infection publication-title: mBio doi: 10.1128/mBio.02749-21 – volume: 29 start-page: 463 year: 2021 end-page: 476 ident: CR19 article-title: Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.02.003 – volume: 586 start-page: 509 year: 2020 end-page: 515 ident: CR86 article-title: Animal models for COVID-19 publication-title: Nature doi: 10.1038/s41586-020-2787-6 – volume: 2 start-page: 100354 year: 2021 ident: CR41 article-title: Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100354 – volume: 2 start-page: 100405 year: 2021 ident: CR56 article-title: Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100405 – volume: 19 start-page: 800 year: 2016 end-page: 813 ident: CR71 article-title: Both neutralizing and non-neutralizing human H7N9 influenza vaccine-induced monoclonal antibodies confer protection publication-title: Cell Host Microbe doi: 10.1016/j.chom.2016.05.014 – volume: 38 start-page: 7892 year: 2020 ident: 4690_CR79 publication-title: Vaccine doi: 10.1016/j.vaccine.2020.10.064 – volume: 7 start-page: eabg7996 year: 2021 ident: 4690_CR113 publication-title: Sci. Adv. doi: 10.1126/sciadv.abg7996 – volume: 19 start-page: e3001284 year: 2021 ident: 4690_CR97 publication-title: PLoS Biol. doi: 10.1371/journal.pbio.3001284 – ident: 4690_CR121 doi: 10.1126/scitranslmed.abn9243 – volume: 370 start-page: 89 year: 2020 ident: 4690_CR62 publication-title: Science doi: 10.1126/science.abd3871 – volume: 586 start-page: 516 year: 2020 ident: 4690_CR1 publication-title: Nature doi: 10.1038/s41586-020-2798-3 – volume: 182 start-page: 734 year: 2020 ident: 4690_CR89 publication-title: Cell doi: 10.1016/j.cell.2020.06.010 – volume: 373 start-page: eabj0299 year: 2021 ident: 4690_CR110 publication-title: Science doi: 10.1126/science.abj0299 – volume: 174 start-page: 938 year: 2018 ident: 4690_CR47 publication-title: Cell doi: 10.1016/j.cell.2018.07.033 – volume: 54 start-page: 2159 year: 2021 ident: 4690_CR104 publication-title: Immunity doi: 10.1016/j.immuni.2021.08.013 – volume: 371 start-page: eabf4063 year: 2021 ident: 4690_CR64 publication-title: Science doi: 10.1126/science.abf4063 – volume: 586 start-page: 578 year: 2020 ident: 4690_CR78 publication-title: Nature doi: 10.1038/s41586-020-2608-y – volume: 586 start-page: 583 year: 2020 ident: 4690_CR55 publication-title: Nature doi: 10.1038/s41586-020-2607-z – volume: 117 start-page: 16587 year: 2020 ident: 4690_CR100 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2009799117 – volume: 2 start-page: 100355 year: 2021 ident: 4690_CR6 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100355 – volume: 602 start-page: 664 year: 2022 ident: 4690_CR115 publication-title: Nature doi: 10.1038/s41586-021-04386-2 – volume: 184 start-page: 3936 year: 2021 ident: 4690_CR43 publication-title: Cell doi: 10.1016/j.cell.2021.06.005 – volume: 20 start-page: 143 year: 2014 ident: 4690_CR48 publication-title: Nat. Med. doi: 10.1038/nm.3443 – volume: 184 start-page: 3467 year: 2021 ident: 4690_CR84 publication-title: Cell doi: 10.1016/j.cell.2021.05.040 – volume: 27 start-page: 2012 year: 2021 ident: 4690_CR57 publication-title: Nat. Med. doi: 10.1038/s41591-021-01488-2 – volume: 182 start-page: 1295 year: 2020 ident: 4690_CR21 publication-title: Cell doi: 10.1016/j.cell.2020.08.012 – volume: 11 year: 2020 ident: 4690_CR91 publication-title: Nat. Commun. doi: 10.1038/s41467-020-19891-7 – volume: 369 start-page: 1010 year: 2020 ident: 4690_CR82 publication-title: Science doi: 10.1126/science.abd0827 – volume: 592 start-page: 283 year: 2021 ident: 4690_CR77 publication-title: Nature doi: 10.1038/s41586-021-03275-y – volume: 603 start-page: 687 year: 2022 ident: 4690_CR106 publication-title: Nature doi: 10.1038/s41586-022-04441-6 – volume: 2 start-page: 100405 year: 2021 ident: 4690_CR56 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100405 – volume: 118 start-page: e2106535118 year: 2021 ident: 4690_CR103 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.2106535118 – volume: 305 start-page: 371 year: 2004 ident: 4690_CR37 publication-title: Science doi: 10.1126/science.1097211 – ident: 4690_CR120 doi: 10.1101/2022.01.03.22268599 – volume: 374 start-page: eabm0829 year: 2021 ident: 4690_CR65 publication-title: Science doi: 10.1126/science.abm0829 – volume: 11 year: 2020 ident: 4690_CR35 publication-title: Nat. Commun. doi: 10.1038/s41467-020-17892-0 – volume: 2 start-page: 100354 year: 2021 ident: 4690_CR41 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100354 – volume: 325 start-page: 1037 year: 2021 ident: 4690_CR3 publication-title: JAMA doi: 10.1001/jama.2021.2294 – volume: 27 start-page: 841 year: 2020 ident: 4690_CR24 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.04.004 – volume: 184 start-page: 1804 year: 2021 ident: 4690_CR58 publication-title: Cell doi: 10.1016/j.cell.2021.02.026 – ident: 4690_CR13 – volume: 182 start-page: 429 year: 2020 ident: 4690_CR32 publication-title: Cell doi: 10.1016/j.cell.2020.05.042 – volume: 57 start-page: e100 year: 2020 ident: 4690_CR44 publication-title: Curr. Protoc. Microbiol. doi: 10.1002/cpmc.100 – volume: 296 start-page: 1439 year: 2002 ident: 4690_CR68 publication-title: Science doi: 10.1126/science.1069660 – volume: 2 start-page: 100290 year: 2021 ident: 4690_CR52 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100290 – volume: 6 start-page: eabj1750 year: 2021 ident: 4690_CR66 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abj1750 – volume: 12 year: 2021 ident: 4690_CR87 publication-title: Nat. Commun. doi: 10.1038/s41467-021-21118-2 – volume: 370 start-page: 1227 year: 2020 ident: 4690_CR38 publication-title: Science doi: 10.1126/science.abd7728 – volume: 589 start-page: 603 year: 2021 ident: 4690_CR95 publication-title: Nature doi: 10.1038/s41586-020-2943-z – volume: 386 start-page: 1088 year: 2022 ident: 4690_CR116 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc2119912 – volume: 12 start-page: e03617 year: 2021 ident: 4690_CR45 publication-title: mBio doi: 10.1128/mBio.03617-20 – volume: 1 start-page: 100040 year: 2020 ident: 4690_CR40 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2020.100040 – volume: 2 start-page: 100255 year: 2021 ident: 4690_CR18 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100255 – volume: 22 start-page: 1306 year: 2021 ident: 4690_CR111 publication-title: Nat. Immunol. doi: 10.1038/s41590-021-01021-0 – volume: 12 year: 2021 ident: 4690_CR108 publication-title: Nat. Commun. doi: 10.1038/s41467-021-26178-y – volume: 373 start-page: 1372 year: 2021 ident: 4690_CR7 publication-title: Science doi: 10.1126/science.abj4176 – volume: 346 start-page: 996 year: 2014 ident: 4690_CR36 publication-title: Science doi: 10.1126/science.1256427 – volume: 183 start-page: 1508 year: 2020 ident: 4690_CR50 publication-title: Cell doi: 10.1016/j.cell.2020.10.052 – ident: 4690_CR61 doi: 10.1126/scitranslmed.abm2311 – volume: 586 start-page: 509 year: 2020 ident: 4690_CR86 publication-title: Nature doi: 10.1038/s41586-020-2787-6 – volume: 602 start-page: 682 year: 2022 ident: 4690_CR122 publication-title: Nature doi: 10.1038/s41586-022-04399-5 – volume: 23 start-page: 3202 year: 2005 ident: 4690_CR114 publication-title: Vaccine doi: 10.1016/j.vaccine.2004.11.075 – volume: 110 start-page: 13492 year: 2013 ident: 4690_CR69 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1221555110 – volume: 14 start-page: eabm3302 year: 2021 ident: 4690_CR99 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abm3302 – volume: 374 start-page: 1343–1353 year: 2021 ident: 4690_CR30 publication-title: Science doi: 10.1126/science.abl8912 – volume: 185 start-page: 113 year: 2022 ident: 4690_CR112 publication-title: Cell doi: 10.1016/j.cell.2021.12.002 – volume: 592 start-page: 116 year: 2021 ident: 4690_CR105 publication-title: Nature doi: 10.1038/s41586-020-2895-3 – volume: 73 start-page: 103626 year: 2021 ident: 4690_CR8 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103626 – volume: 182 start-page: 812 year: 2020 ident: 4690_CR5 publication-title: Cell doi: 10.1016/j.cell.2020.06.043 – volume: 29 start-page: 1093 year: 2021 ident: 4690_CR4 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.05.012 – volume: 53 start-page: 524 year: 2020 ident: 4690_CR51 publication-title: Immunity doi: 10.1016/j.immuni.2020.07.020 – volume: 29 start-page: 747 year: 2021 ident: 4690_CR29 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.04.007 – volume: 588 start-page: 682 year: 2020 ident: 4690_CR17 publication-title: Nature doi: 10.1038/s41586-020-2852-1 – volume: 26 start-page: 1033 year: 2020 ident: 4690_CR39 publication-title: Nat. Med. doi: 10.1038/s41591-020-0913-5 – volume: 93 start-page: e01696 year: 2019 ident: 4690_CR46 publication-title: J. Virol. doi: 10.1128/JVI.01696-18 – volume: 29 start-page: 463 year: 2021 ident: 4690_CR19 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.02.003 – volume: 28 start-page: 475 year: 2020 ident: 4690_CR33 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.06.021 – ident: 4690_CR42 doi: 10.1016/j.ebiom.2021.103626 – volume: 218 start-page: e20201993 year: 2021 ident: 4690_CR59 publication-title: J. Exp. Med. doi: 10.1084/jem.20201993 – volume: 19 start-page: 800 year: 2016 ident: 4690_CR71 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2016.05.014 – ident: 4690_CR98 doi: 10.1101/2021.01.19.21249592 – volume: 13 start-page: eabh0755 year: 2021 ident: 4690_CR107 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abh0755 – ident: 4690_CR22 doi: 10.1101/2021.09.07.21263228 – volume: 87 start-page: 5512 year: 2013 ident: 4690_CR73 publication-title: J. Virol. doi: 10.1128/JVI.03030-12 – volume: 592 start-page: 116 year: 2020 ident: 4690_CR74 publication-title: Nature doi: 10.1038/s41586-020-2895-3 – ident: 4690_CR14 – volume: 590 start-page: 630 year: 2021 ident: 4690_CR54 publication-title: Nature doi: 10.1038/s41586-020-03041-6 – volume: 185 start-page: 847 year: 2022 ident: 4690_CR119 publication-title: Cell doi: 10.1016/j.cell.2022.01.015 – volume: 12 start-page: e0274921 year: 2021 ident: 4690_CR96 publication-title: mBio doi: 10.1128/mBio.02749-21 – volume: 602 start-page: 676 year: 2022 ident: 4690_CR118 publication-title: Nature doi: 10.1038/s41586-021-04388-0 – volume: 325 start-page: 1467 year: 2021 ident: 4690_CR34 publication-title: JAMA doi: 10.1001/jama.2021.3341 – volume: 12 start-page: e1005578 year: 2016 ident: 4690_CR72 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1005578 – volume: 371 start-page: 850 year: 2021 ident: 4690_CR20 publication-title: Science doi: 10.1126/science.abf9302 – volume: 6 start-page: e00159 year: 2021 ident: 4690_CR85 publication-title: mSphere doi: 10.1128/mSphere.00159-21 – volume: 27 start-page: 1205 year: 2021 ident: 4690_CR27 publication-title: Nat. Med. doi: 10.1038/s41591-021-01377-8 – volume: 21 start-page: 1327 year: 2020 ident: 4690_CR92 publication-title: Nat. Immunol. doi: 10.1038/s41590-020-0778-2 – volume: 3 start-page: 100529 year: 2022 ident: 4690_CR117 publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2022.100529 – ident: 4690_CR16 doi: 10.1016/j.celrep.2022.110829 – volume: 96 start-page: JVI0111021 year: 2021 ident: 4690_CR10 publication-title: J. Virol. doi: 10.1128/JVI.01110-21 – volume: 3 start-page: e235 year: 2021 ident: 4690_CR75 publication-title: Lancet Microbe doi: 10.1016/S2666-5247(21)00266-4 – volume: 602 start-page: 294 year: 2022 ident: 4690_CR25 publication-title: Nature doi: 10.1038/s41586-021-04245-0 – volume: 27 start-page: 717 year: 2021 ident: 4690_CR31 publication-title: Nat. Med. doi: 10.1038/s41591-021-01294-w – volume: 12 year: 2021 ident: 4690_CR83 publication-title: Nat. Commun. doi: 10.1038/s41467-021-26239-2 – volume: 599 start-page: 465 year: 2021 ident: 4690_CR60 publication-title: Nature doi: 10.1038/s41586-021-04017-w – volume: 32 start-page: 107940 year: 2020 ident: 4690_CR81 publication-title: Cell Rep. doi: 10.1016/j.celrep.2020.107940 – volume: 13 start-page: eabi4547 year: 2021 ident: 4690_CR109 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abi4547 – volume: 154 start-page: 323 year: 1988 ident: 4690_CR9 publication-title: Acta Chir. Scand. – volume: 16 start-page: e0248348 year: 2021 ident: 4690_CR11 publication-title: PLoS ONE doi: 10.1371/journal.pone.0248348 – volume: 27 start-page: 620 year: 2021 ident: 4690_CR26 publication-title: Nat. Med. doi: 10.1038/s41591-021-01270-4 – volume: 88 start-page: 8242 year: 2014 ident: 4690_CR70 publication-title: J. Virol. doi: 10.1128/JVI.01164-14 – volume: 103 start-page: 1215 year: 2020 ident: 4690_CR94 publication-title: Am. J. Trop. Med. Hyg. doi: 10.4269/ajtmh.20-0762 – volume: 30 start-page: 373 year: 2022 ident: 4690_CR15 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2022.01.006 – volume: 17 start-page: e1009758 year: 2021 ident: 4690_CR90 publication-title: PLoS Pathog. doi: 10.1371/journal.ppat.1009758 – volume: 131 start-page: e116 year: 2020 ident: 4690_CR28 publication-title: Curr. Protoc. Immunol. doi: 10.1002/cpim.116 – volume: 586 start-page: 567 year: 2020 ident: 4690_CR76 publication-title: Nature doi: 10.1038/s41586-020-2622-0 – volume: 36 start-page: 109400 year: 2021 ident: 4690_CR101 publication-title: Cell Rep. doi: 10.1016/j.celrep.2021.109400 – volume: 29 start-page: 508 year: 2021 ident: 4690_CR2 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2021.02.020 – volume: 5 start-page: e142032 year: 2020 ident: 4690_CR93 publication-title: JCI Insight doi: 10.1172/jci.insight.142032 – volume: 81 start-page: 813 year: 2007 ident: 4690_CR88 publication-title: J. Virol. doi: 10.1128/JVI.02012-06 – volume: 583 start-page: 834 year: 2020 ident: 4690_CR102 publication-title: Nature doi: 10.1038/s41586-020-2342-5 – volume: 596 start-page: 268 year: 2021 ident: 4690_CR67 publication-title: Nature doi: 10.1038/s41586-021-03681-2 – volume: 18 start-page: 46 year: 2018 ident: 4690_CR49 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2017.106 – volume: 6 start-page: eabh3634 year: 2021 ident: 4690_CR12 publication-title: Sci. Immunol. doi: 10.1126/sciimmunol.abh3634 – volume: 16 start-page: e0247640 year: 2021 ident: 4690_CR53 publication-title: PLoS ONE doi: 10.1371/journal.pone.0247640 – volume: 9 start-page: e0180321 year: 2021 ident: 4690_CR23 publication-title: Microbiol. Spectr. doi: 10.1128/Spectrum.01803-21 – volume: 181 start-page: 1489 year: 2020 ident: 4690_CR63 publication-title: Cell doi: 10.1016/j.cell.2020.05.015 – volume: 12 year: 2021 ident: 4690_CR80 publication-title: Nat. Commun. doi: 10.1038/s41467-020-20653-8 |
| SSID | ssj0005174 |
| Score | 2.6605308 |
| SecondaryResourceType | review_article |
| Snippet | The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after... The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variantsjeopardizes the protective antiviral immunity induced after... The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced... |
| SourceID | pubmedcentral hal proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 640 |
| SubjectTerms | 631/250/590 692/699/255/2514 Allergies Animal models Animals Antiviral drugs Bioinformatics Biological Evolution Collaboration Coronaviruses COVID-19 COVID-19 Vaccines Disease transmission Evolution Evolution & development Genomes Health risks Human populations Humanities and Social Sciences Humans Immunity Infections Infectious diseases Life Sciences Microbiology and Parasitology multidisciplinary Mutation National Institute of Allergy and Infectious Diseases (U.S.) Pandemics Pandemics - prevention & control Peer review Perspective Pharmacogenomic Variants Proteins Public health R&D Reagents Research & development Respiratory diseases Risk assessment Risk communication SARS-CoV-2 - genetics SARS-CoV-2 - pathogenicity Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 Teams United States - epidemiology Vaccines Viral diseases Virology Virulence Viruses |
| Title | Defining the risk of SARS-CoV-2 variants on immune protection |
| URI | https://link.springer.com/article/10.1038/s41586-022-04690-5 https://www.ncbi.nlm.nih.gov/pubmed/35361968 https://www.proquest.com/docview/2670682016 https://www.proquest.com/docview/2646724564 https://hal.science/hal-04794622 https://pubmed.ncbi.nlm.nih.gov/PMC9345323 |
| Volume | 605 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED7RTUhICG0FRmCrDOIBBNYSO3aSB4S6slIhmNDGUN-i-Ee1SVOykW5__3yO26qb2EseEkeJfWffne_zdwDvFbfGcmUpq3hKUzPjVEmhqDKFrVSGJFqY0f11JCen6Y-pmIYNtzbAKhdrol-oTaNxj3yfySyWaK7k18srilWjMLsaSmj0YDNxlgYhXfn4-wricYeFORyaiXm-3zrDlSP8llEfIVKxZph6ZwiLvO9z3odO3smferM03oJnwZ8kw04BtuGRrfvw2OM6dduHp922HOlOG_VhO8zllnwIhNMfn8OXb3bm60QQ5w0SBJuTZkZOhscndNT8pYzcuIAa8TKkqck5HiixJPA7OKm-gNPx4Z_RhIayClQ7b2xOnUGfGWaKwgihE204s3FspEi1G11tRKZjWTmvscry2HDhoufCObUqj3khq9xU_CVs1E1tXwFRSqVxZSvpwzydKiNsobTkGVeCGR1BshjTUgfOcSx9cVH63DfPy04OpZND6eVQigg-Ld-57Bg3Hmz9zolq2RDJsifDnyXe68jzGbtJIthdSLIMU7QtVwoVwdvlYze5MGNS1ba5xjbOjmBqOI1gpxP88lNccBd8yjyCbE0l1v5l_Ul9fuYJvAueCs54BJ8XyrP6rf939fXDvXgDT5hXZ0Qt7sLG_N-13XMO01wNoJdNM3fNR8nAz5ABbB4cHv0-vgXebxDl |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB61RQgkhOjyChQwCCQQWM3asZMcKrRqWbZ02wNtUW8mfqxaCSWFbIv4U_xGPE6yq21Fb70mznPGnhnPN98AvNbcWce1o6zgCU3shFMthaba5q7QKZJoYUZ3d0-ODpMvR-JoCf52tTAIq-zWxLBQ28rgHvk6k2ks0VzJj6c_KXaNwuxq10KjUYsd9-e3D9nqje0tL983jA0_HWyOaNtVgBrvjEypt2cTy2yeWyFM31jOXBxbKRLjb26sSE0sC-80FWkWWy588Jh7n05nMc9lkdmC-_suw42Ee0uOlenDz3NIyQXW57ZIJ-bZeu0NZYZwX0ZDRErFgiFcPkYY5mUf9zJU80K-NpjB4T242_qvZNAo3CosubIHNwOO1NQ9uNNsA5KmuqkHq-3aUZO3LcH1u_uwseUmoS8F8d4nQXA7qSZkf_B1n25W3ygj5z6AR3wOqUpyggUsjrR8El6LHsDhtfzwh7BSVqV7DERrncSFK2QIK02irXC5NpKnXAtmTQT97p8q03KcY6uNHyrk2nmmGjkoLwcV5KBEBO9n15w2DB9Xjn7lRTUbiOTco8FY4bGGrJ-x834Ea50kVbsk1GquwBG8nJ32kxkzNEXpqjMc4-0WpqKTCB41gp89igvug12ZRZAuqMTCuyyeKU-OA2F4zhPBGY_gQ6c889f6_6c-uforXsCt0cHuWI2393aewm0WVBsRk2uwMv115p55Z22qn4cZQuD7dU_JfwlkSR0 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tT9RAEJ4ARmNijJxvVdTVaKKRzfV2u9v2AzGXOy-HIDEChm-l-9JAYlq0B8a_5q9zZ9seHkS-8bXdvs7MzszOs88AvFbcGsuVpSznEY1MwamSQlFlUpurGEm0sKL7eUdO96NPB-JgCf50e2EQVtnNiX6iNpXGNfI-k3Eo0V3JftHCIr6MJx9OflDsIIWV1q6dRqMiW_b3L5e-1RubYyfrN4xNPu6NprTtMEC1C0xm1Pm2wjCTpkYIPdCGMxuGRopIuwdpI2IdytwFUHmchIYLl0imLr5TSchTmScm5-6-y3Aj5nGCNpaM_oGXXGCAbjfshDzp185pJgj9ZdRnp1QsOMXlI4RkXo53L8M2L9RuvUuc3IO7bSxLho3yrcKSLXtw02NKdd2DO82SIGl2OvVgtZ1HavK2Jbt-dx82xrbwPSqIi0QJAt1JVZDd4dddOqq-UUbOXDKPWB1SleQYN7NY0nJLOI16APvX8sMfwkpZlfYxEKVUFOY2lz7F1JEywqZKSx5zJZjRAQy6f5rplu8c2258z3zdnSdZI4fMySHzcshEAO_n15w0bB9Xjn7lRDUfiETd0-F2hsca4n7GzgYBrHWSzNrpoc7OlTmAl_PTzrCxWpOXtjrFMc6HYVk6CuBRI_j5o7jgLvGVSQDxgkosvMvimfL4yJOHpzwSnPEA1jvlOX-t_3_qk6u_4gXccsaYbW_ubD2F28xrNoIn12Bl9vPUPnNx20w99wZC4PC6LfIvYTRNHg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Defining+the+risk+of+SARS-CoV-2+variants+on+immune+protection&rft.jtitle=Nature+%28London%29&rft.au=DeGrace%2C+Marciela+M&rft.au=Ghedin%2C+Elodie&rft.au=Krammer%2C+Florian&rft.au=Grifoni%2C+Alba&rft.date=2022-05-26&rft.pub=Nature+Publishing+Group&rft.issn=0028-0836&rft.eissn=1476-4687&rft.volume=605&rft.issue=7911&rft.spage=640&rft.epage=652&rft_id=info:doi/10.1038%2Fs41586-022-04690-5&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-0836&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-0836&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-0836&client=summon |